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GenerAl InTrOduCTIOn
In orthopedic surgery, primary total hip arthroplasty (THA) is a very commonly per-
formed surgery worldwide. It is one of the most cost-effective interventions available 
in modern surgery, which has been performed since the end of the 19th century with 
satisfying clinical results.1,2 Nowadays THA is a good option for patients with end-stage 
osteoarthritis of the hip if conservative treatment fails to alleviate pain and limitations.3,4 
There is general agreement about the effectiveness of the surgical procedure and surgi-
cal techniques. Prostheses have also improved in recent years. However, the challenge 
remains to optimize perioperative care for patients undergoing primary THA. 
In the past few years the number of registered THAs in the Netherlands increased from 
22.943 in 2010 to 25.642 in 2013.5 Due to the aging population and the related increase in 
the prevalence of osteoarthritis of the hip, a further increase in the number of primary 
THAs is to be expected.6,7 This underscores the importance of optimized perioperative 
care for patients undergoing this procedure. 
Efforts to achieve optimized perioperative care should focus on reducing the burden 
for the patient, by reducing length of hospital stay (LOS), rehabilitation time, postop-
erative pain, and complications after primary THA. Several aspects of the perioperative 
procedure for primary THA may contribute to reducing this patient burden. Three of 
these aspects are discussed below.
lenGTH Of HOsPITAl sTAY 
Postoperative care has evolved from various medical traditions. One of those tradi-
tions is bed rest after surgery.8 Historically, LOS after primary THA amounted to several 
weeks,9 including a long period of bed rest. However, bed rest increases muscle loss 
and weakness, impairs pulmonary function and tissue oxygenation, and predisposes to 
thrombo-embolic and pulmonary complications and orthostatic intolerance.10
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In the past few years, there has been a continued interest in improving results after 
primary THA. Several studies have focused on the successful implementation of fast-
track protocols for primary THA in both selected and unselected groups of patients.8,9,11-19 
These fast-track protocols are based on analysis of core care principles and effective pain 
management and efficient organization, allowing for optimized and safe perioperative 
care.8,12,13,18 As a result, these protocols led to safe and rapid early rehabilitation, reduc-
tion of complications, reduction of bed rest, and hence reduction of LOS and a decrease 
of the use of hospital resources.8 
However, previous studies have shown that LOS after primary THA is not only 
determined by organizational factors and medical traditions, but also by patient char-
acteristics.14,19,20-32 The proper identification of patients who need more rehabilitation 
time and extensive care after THA might provide further optimization of discharge and 
rehabilitation planning, even in a fast-track setting.
surGICAl PrOCedure 
Although there is general agreement about the effectiveness of the surgical proce-
dure itself, various surgical approaches for primary THA have been described.33 In the 
Netherlands 61.3 % of the primary THAs in 2013 were placed using a posterolateral ap-
proach and 21.9 % with a straight lateral approach, while only 9.9 % used the anterior 
approach.5 Each of these approaches has its own advantages and disadvantages. 
Von Langenbeck initially described the posterolateral approach, which uses a split 
of the gluteus maximus muscle and remains posterior to the medial and minimal glu-
teal muscles.34 The posterior hip capsule is incised, followed by a detachment of the 
pirifomis, superior and inferior gemelli and obturator internus muscle.35 This approach 
provides good exposure of both the acetabulum and the proximal femur. Furthermore it 
preserves the abductor function.36 However, higher dislocation rates have been reported 
for this approach when compared to other approaches to the hip joint.37-40 
The straight lateral approach is also one of the principal methods for THA.41 It provides 
complete and continuous observation of the entire hip and surrounding structures, 
which allows adequate access for orientation of the implant.33,35,42 Disadvantages of 
this approach are moderate muscle and tendon trauma, and a tendency to develop a 
Trendelenburg gait and trochanteric bursitis after postoperative recovery.33,35,43
The anterior approach was already described by Carl Hueter in 1870,44 and was first 
used for a primary hip replacement by Robert Judet in 1947.45 In this approach, both 
intermuscular and internervous planes are used. Due to this anatomical approach, 
several advantages have been described in literature.33,45-58 Preservation of muscle 
attachments might improve stability and reduce the risk of dislocation after surgery. 
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Furthermore, studies on this approach reported shorter rehabilitation time, shorter LOS, 
less surgical trauma and hence less blood loss and less pain. However this approach has 
its own unique set of complications and is sometimes criticized because of its technical 
difficulty.33,43,46,47,56,59-63
Since all approaches have their own advantages and disadvantages, there is still no 
consensus in literature which approach is most suitable for primary THA. In the past few 
years, the anterior approach is gaining popularity in the Netherlands, with an increase 
from 4.2% in 2010 to 9.9% in 2013 of all primary THAs.5 However, there is an ongoing de-
bate whether this still less frequently used approach is preferable to other approaches 
to the hip joint and whether the possible benefits of this approach outweigh the pos-
sible disadvantages.
PAIn MAnAGeMenT 
THA is associated with considerable postoperative pain.1 Almost all pain after surgery 
arises as a result of tissue damage at the surgical site.64 Formation of hematoma is also 
suggested to contribute to postoperative pain after THA.65 This postoperative pain 
hinders early mobilization and rehabilitation, which has negative consequences on 
mobility, LOS and duration of overall recovery.66 Analgesics are used to provide pain 
relief. However, most analgesics are known for their side effects, such as nausea, vomit-
ing, dizziness or numbness of the limb, which could hinder postoperative mobilization 
and rehabilitation. Therefore, the challenge of analgesic regimes for THA is to obtain 
adequate pain relief in combination with maximum muscle control and without trouble-
some side effects. This will enable the patient to mobilize and rehabilitate early and 
safely, without pain.67
As part of perioperative pain treatment, local infiltration analgesia (LIA) has been 
described in literature.64 LIA is a technique in which the surgical field is infiltrated with 
analgesics in order to provide better pain relief postoperatively. An analgesic used for 
this technique is ropivacaine.64 LIA has been reported to be effective in total knee ar-
throplasty (TKA).66,68,69 However, for THA only limited and inconclusive data are available 
from placebo-controlled and randomized trials.1,67,70-74 None of these studies report on 
the use of LIA for primary THA by anterior approach. Moreover, although several studies 
describe pharmacokinetics of ropivacaine after epidural and intravenous administra-
tion,75-78 pharmacokinetic parameters of ropivacaine for the application route of LIA 
for THA have not been investigated yet. The analgesic effect of LIA could possibly be 
improved by determining the concentration-time correlation of ropivacaine in serum 
after LIA in THA. Moreover, a statement can be made about toxicity of the determined 
ropivacaine serum levels after LIA for THA.
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Furthermore, previous studies have shown that postoperative pain after primary 
THA is influenced by patient characteristics. The proper identification of patients who 
experience more postoperative pain might provide further insight into how pain is 
experienced by patients. Also, it may help to further optimize the postoperative pain 
management and the preoperative education of these THA patients. 
OuTlIne Of THIs THesIs 
The aim of this thesis is to investigate how perioperative care for primary THA patients 
could be optimized. Three main aspects of the perioperative procedure are therefore 
studied, all with several objectives:  
• Length of hospital stay: Reducing LOS after primary THA without an increase in com-
plications, re-admissions and reoperations. Also, identifying patient characteristics 
influencing LOS after primary THA.
• Surgical procedure: Investigating the anterior approach in comparison to other 
approaches for THA. Furthermore, summarizing possible advantages and disadvan-
tages of this approach together with possibilities for solving these disadvantages.
• Pain management: Investigating if LIA has added value in a multimodal pain treat-
ment protocol for primary THA by anterior approach. Furthermore, elucidating 
pharmacokinetic parameters of ropivacaine administered by LIA in THA patients. 
Also, identifying which patient-specific and surgical characteristics influence post-
operative pain after primary THA in a fast-track setting. 
Chapter 2 demonstrates the results of the introduction of a fast-track protocol for primary 
THA in Reinier de Graaf Hospital (RdGG) in the Netherlands. Differences in LOS before, 
during and after the introduction of a fast-track protocol for primary THA procedures for 
a group of unselected patients are analyzed. Furthermore, the number of complications, 
re-admissions and reoperations for this group are analyzed. It was hypothesized that 
LOS would decrease, without an increase in complications, re-admissions and reop-
erations. Chapter 3 reports experiences with THA in an outpatient setting for a group of 
selected patients at RdGG. Furthermore this chapter investigates if postoperative results 
for this group of patients are satisfying for both the patient and the orthopedic surgeon. 
Chapter 4 demonstrates which specific patient characteristics influenced prolonged 
LOS after the successful implementation of a fast-track protocol. Despite the reduction 
in mean LOS after the implementation of a fast-track protocol, there was still a large 
range in LOS with several outliers. The proper identification of patients who need more 
rehabilitation time and extensive care might allow for further optimization of discharge 
and rehabilitation planning. 
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Regarding the anterior approach for primary THA, chapter 5 summarizes literature re-
garding advantages as well as disadvantages for this approach. The anterior approach is 
compared to other approaches to the hip with respect to several perioperative and post-
operative aspects. This systematic review hypothesized that patients operated through 
the anterior approach recover faster and experience less postoperative pain than those 
operated by means of other approaches, since muscle attachments are preserved. Sec-
ondly, it was hypothesized that there were no other differences in outcome parameters 
between the anterior approach and other approaches. Furthermore, this chapter inves-
tigates if there is a clear description of a learning curve for surgeons using the anterior 
approach. Chapter 6 describes specific complications noticed during the first unselected 
cases operated by means of the anterior approach (anterior supine intermuscular (ASI) 
approach), for primary THA at RdGG. Furthermore, this chapter describes specific adjust-
ments that were applied to this procedure to prevent these complications. 
Considering the optimization of pain treatment for primary THA, chapter 7 focuses 
on perioperative pain management. It was hypothesized that LIA implemented in a 
multimodal pain protocol for THA through the anterior approach reduces pain scores 
postoperatively. Also, a reversed-infiltration method is introduced in this chapter, in 
which LIA is administered before the incisions have been made. It was hypothesized 
that this infiltration method would reduce postoperative pain scores even further, since 
LIA can be infiltrated more accurately in tissues that have not been damaged. Therefore, 
this chapter investigates the effect of both standard and reversed LIA in combination 
with the anterior approach for primary THA. Chapter 8 focuses on the elucidation of 
pharmacokinetic parameters of ropivacaine administered by LIA in THA patients, by 
determining the concentration-time correlation of ropivacaine in serum. With clarified 
pharmacokinetic parameters of ropivacaine after THA, the analgesic effect of LIA could 
possibly be improved. Furthermore, recommendations about the dose of ropivacaine in 
LIA for THA can be given. Moreover, a statement can be made about toxicity of the de-
termined ropivacaine serum levels after LIA for THA. Finally, Chapter 9 investigates which 
patient-specific and surgical characteristics influence postoperative pain after primary 
THA by means of the anterior approach in a fast-track setting. The proper identification 
of patients who experience more postoperative pain after primary THA might allow for 
further optimization of postoperative pain management and preoperative education of 
these patients.
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AbsTrACT
Rapid recovery protocols after total hip arthroplasty (THA) haven been introduced 
worldwide in the last few years and they have reduced the length of hospital stay. We 
show the results of the introduction of a rapid recovery protocol for primary THA for 
unselected patients in our large teaching hospital.
In a retrospective cohort study, we included all 1,180 patients who underwent a primary 
THA between July 1, 2008 and June 30, 2012. These patients were divided into 3 groups: 
patients operated before, during, and after the introduction of the rapid recovery proto-
col. There were no exclusion criteria. All complications, re-admissions, and reoperations 
were registered and analysed.
The mean length of hospital stay decreased from 4.6 to 2.9 nights after the introduction 
of the rapid recovery protocol. There were no statistically significant differences in the 
rate of complications, re-admissions, or reoperations between the 3 groups.
In conclusion, in a large teaching hospital, the length of hospital stay decreased after 
introduction of our protocol for rapid recovery after THA in unselected patients, without 
any increase in complications, re-admissions, or reoperation rate.
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InTrOduCTIOn 
Historically, the length of hospital stay after primary THA has exceeded several weeks,1 
with a subsequent period of bed rest. In the last few years, rapid recovery protocols 
haven been introduced worldwide for elective primary THA. Various studies have shown 
that these protocols have reduced the length of hospital stay and the length of reha-
bilitation after primary THA.1-9 Also a decrease in complication rate2 and in re-admission 
rate3 has been described. These rapid recovery protocols are based on analysis of clinical 
care principles and pain management in combination with revision of organizational 
factors, giving an optimized perioperative period that is safe for the patient.8,10
Reinier de Graaf Hospital (RdGG) is a large teaching hospital in the Netherlands. 
Introduction of the rapid recovery protocol for primary THA started in 2009, was done 
in several stages, and was complete in February 2011. In the present study, we analysed 
the differences in length of hospital stay before, during and after introduction of the 
rapid recovery protocol for primary THA procedures in a group of unselected patients at 
RdGG. We also examined the amount of complications, re-admissions, and reoperations 
for this group after introduction of the rapid recovery protocol.
PATIenTs And MeTHOds
In this retrospective cohort study, we included all the patients who underwent a primary 
THA procedure between July 1, 2008 and June 30, 2012. There were no exclusion criteria; 
every patient who received a primary THA was included. The patients were divided into 
3 groups, based on the period in which the surgery was performed. Group 1 had patients 
who were operated in the period before the rapid recovery protocol was introduced. 
Group 2 had patients who were operated between January 1, 2009 and January 31, 2011, 
during the period in which the rapid recovery protocol was introduced in several stages. 
Group 3 had patients who were operated after all the stages of the rapid recovery proto-
col had been introduced (Table 1).
All the patients had the same regimen. The discharge criteria were functional: patient 
able to walk 30 metres with crutches, to climb stairs, to dress independently, and to go 
to the toilet independently. In addition, sufficient pain treatment had to be achieved by 
oral medication before discharge, with VAS below 3 at rest and below 5 during mobiliza-
tion.
Various surgical approaches were used - the straight lateral (SL) approach, the anterior 
supine intermuscular (ASI) approach, and the posterolateral (PL) approach - according 
to the preference of the surgeon. 15 orthopedic surgeons performed the THA proce-
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dures during this period, either by themselves or by supervising a resident in orthopedic 
surgery.
The fulfilment of discharge criteria was analysed twice a day. Length of hospital stay 
was measured by number of nights. All patients were admitted on the day of surgery. 
Outliers in length of hospital stay were defined as being equal to or more than the 
ninety-fifth percentile. All complications, re-admissions, and reoperations were regis-
tered and analysed.
statistics
Since the data were not normally distributed according to the Kolmogorov-Smirnoff 
test, they were analysed using the Kruskal-Wallis test and the Mann-Whitney test with 
Bonferroni correction. Values of p < 0.05 were considered significant. Data analysis was 
done with IBM SPSS Statistics for Mac, version 20.
resulTs
For the total group of 1,180 patients, the mean age was 71 (22-94) years. More women 
than men were operated (815 as opposed to 265). The main indication for operation was 
primary osteoarthritis (89%). Other indications were posttraumatic arthritis, fracture 
of the femoral neck, avascular necrosis, and development disorders. Mean BMI was 27 
(17-58). The most common ASA classification was ASA II (66%). Spinal anesthesia was 
given in 88% of the cases. Almost all operations were performed in an elective setting 
(98%). Most patients were discharged postoperatively to their own home (81%); others 
went to a temporary nursing home for further rehabilitation (18%) or were discharged to 
another department of our hospital for treatment for non-orthopedic pathology (0.4%). 
Table 1: Rapid Recovery Protocol.
•	 Preoperative education
•	 Local infiltration anesthesia
•	 Standardized protocol for pain medication
•	 Opioid medication only on request (rescue medication)
•	 No compression bandages
•	 No drains
•	 No standard urine catheters
•	 Start rehabilitation and mobilization at day of surgery
•	 Checking the fulfillment of discharge criteria twice a day
•	 Optimization of the aftercare
All the several phases of the rapid recovery protocol. 
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The SL approach was mostly used, followed by the ASI approach and the PL approach. 
The demographic characteristics were equal for the 3 groups; only the surgical approach 
used was significantly different in groups 1 and 2 (Table 2). 
1,180 patients received an unilateral primary THA between July 1, 2008 and June 30, 
2012. In group 1, 157 patients were operated with a mean length of hospital stay of 4.6 
(SD 1.2) nights. Group 2 consisted of 639 patients with a mean hospital stay of 3.7 (SD 1.3) 
nights, and group 3 consisted of 384 patients with a mean hospital stay of 2.9 (SD 1.4) 
nights. The differences in length of hospital stay were statistically significant between all 
3 groups (p < 0.001). Median length of hospital stay decreased from 4 nights to 3 nights 
after the introduction of the rapid recovery protocol (p < 0.001) (Table 3 and Figure 1).
For the total group of 1,180 patients, 3.9% were re-admitted and 2.7% of them under-
went a reoperation within the first 3 months after primary THA. The total reoperation 
rate was 4.6%. There was a decrease in re-admission rate and reoperation rate within 
the first 3 months after surgery and also a decrease in reoperation rate in total, after the 
Table 2: Demographics.
Group 1 Group 2 Group 3 p-value
Age (years) 71 (SD 10) 71 (SD 9) 71 (SD 10) 0.2
Gender (% female) 68.2 69.3 69.0 1.0
BMI (kg/m²) 26.7 (SD 4.3) 27.1 (SD 4.3) 26.9 (SD 4.2) 0.3
ASA classification I 22 20 20 0.9
II 66 66 66
III 13 14 14
IV - - 0.3
Anesthesia (% spinal) 91 87 90 0.06
Priority (% elective) 99 99 98 0.3
Diagnosis (% primary) 93 88 88 0.2
Direction of discharge (%) home 82 82 80 0.7
TNH* 19 18 19
AD† - 0.2 0.8
Approach (%) ASI 27 45 52 < 0.001
SL 73 49 45
PL - 6 4
Side (% right) 56 55 55 1.0
Group 1 represents the patients who were operated in the period before the rapid recovery was introduced. 
Group 2 represents the patients who were operated in the period in which the rapid recovery protocol was intro-
duced in several phases. Group 3 represents the patients who were operated after all the several phases of rapid 
recovery were introduced. 
* TNH = Temporary nursing home for further rehabilitation.
† AD = Another department of our hospital for treatment for non-orthopedic pathology. 
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Table 3: Length of hospital stay, complications, readmissions, and reoperations after primary THA.
Group 1 Group 2 Group 3 p-value
Length of hospital stay Mean 4.6 (SD 1.2) 3.7 (SD 1.3) 2.9 (SD 1.4) < 0.001
Median 4 3 3 < 0.001
Complications (%) 7.6 7.0 7.8 0.9
Readmissions < 3 months (%) 4.5 3.4 4.4 0.7
Reoperations (%) 7.0 4.4 3.9 0.3
Reoperations < 3 months 3.8 2.3 2.9 0.5
Group 1 represents the patients who were operated in the period before the rapid recovery was introduced. 
Group 2 represents the patients who were operated in the period in which the rapid recovery protocol was intro-
duced in several phases. Group 3 represents the patients who were operated after all the several phases of rapid 
recovery were introduced. 
figure 1: Percentage nights in hospital after primary THA for the 3 groups.
Group 1 represents the patients who were operated in the period before the rapid recovery was introduced. 
Group 2 represents the patients who were operated in the period in which the rapid recovery protocol was intro-
duced in several phases. Group 3 represents the patients who were operated after all the several phases of rapid 
recovery were introduced.
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introduction of the rapid recovery protocol, but these decreases were not statistically 
significant (Table 3).
Complication after primary THA occurred u 7.4% of the 1,180 patients, with no sta-
tistically significant differences between the 3 groups. The most common reason for 
both re-admission and reoperation within the first 3 months was infection, followed by 
dislocation, wound problems, and fracture of the femur (Table 4).
In group 1 there were 17 outliers in length of hospital stay (11%), in group 2 there were 
41 outliers (6%), and in group 3 there were 15 outliers (4%). Most outliers in group 1 had a 
prolonged hospital stay without any reason given in the patient charts.
dIsCussIOn
Our findings of reduced length of hospital stay for primary THA after introduction of a 
rapid recovery protocol are in accordance with the results of various other studies.2,4-8
We found a decrease in re-admission rate and reoperation rate within the first 3 months 
after surgery, and also a decrease in reoperation rate in total, but these decreases were 
not statistically significant. This contrasts with previous studies showing a significant 
reduction in complication rate2 and re-admission rate3 within the first 3 months after 
THA after the introduction of a rapid recovery protocol. However, our re-admission rates 
were less than described in other studies even though the reasons for re-admission 
were the same.4-6,11,12 Our reoperation rate is in accordance with the only other study 
that published the reoperation rate for primary THA after the introduction of a rapid 
recovery protocol.5
Table 4: Reasons for readmission within the first 3 months after primary THA.
Group 1 Group 2 Group 3
n=157 n=639 n=384
Infection 5 (3.2%) 6 (0.9%) 7 (1.8%)
Dislocation 2 (1.3%) 9 (1.4%) 3 (0.8%)
Fracture - 2 (0.3%) -
Wound problems - 5 (0.8%) 2 (0.5%)
Malposition prosthesis - - 1 (0.3%)
Anemia - - 3 (0.8%)
Pain, unknown cause - - 1 (0.3%)
Total 7 (4.5%) 22 (3.4%) 17 (4.4%)
Group 1 represents the patients who were operated in the period before the rapid recovery was introduced. 
Group 2 represents the patients who were operated in the period in which the rapid recovery protocol was intro-
duced in several phases. Group 3 represents the patients who were operated after all the several phases of rapid 
recovery were introduced. 
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The proportion of patients discharged tot heir own home or discharged to a tempo-
rary nursing home for further rehabilitation did not change after the introduction of 
the rapid recovery protocol. This is in accordance with the results of a meta-analysis,2 
although another study showed a decrease in patients discharged to their own home 
after the length of hospital stay decreased.9
For group 1, there were 17 outliers in length of hospital stay (10.8), for group 2 there 
were 41 outliers (6.4%), and for group 3 there were 15 outliers (3.9%). These outliers 
were mainly for medical reasons. The introduction of pre-emptive delirium therapy for 
patients at risk reduced the prevalence of delirium and therefore reduced the length of 
prolonged hospital stay. This could explain the decline in outliers after the introduction 
of the rapid recovery protocol, although lack of postoperative delirium has been de-
scribed in fast-track THA and total knee arthroplasty as well.13 A possible reason for this 
occurrence could be the use of tramadol and piritramide in our standardized protocol 
for pain medication, both of which are opioids.
In conclusion, in our large teaching hospital implementation of the rapid recovery 
protocol led to a decrease in length of hospital stay for unselected THA patients, without 
any change in complication rate, re-admission rate, or reoperation rate. The re-admission 
rate was less than reported in other studies, but the reoperation rate was similar to that 
in other studies.
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AbsTrACT
As a result of introduction of a fast- track program, length of hospital stay after total 
hip arthroplasty (THA) decreased in our hospital. We therefore wondered whether THA 
in an outpatient setting would be feasible. We report our experience with THA in an 
outpatient setting.
In this prospective cohort study, we included 27 patients who were selected to receive 
primary THA in an outpatient setting between April and July 2014. Different patient-
reported outcome measures (PROMs) were recorded preoperatively and at 6 weeks and 
3 months postoperatively. Furthermore, anchor questions on how patients functioned 
in daily living were scored at 6 weeks and 3 months postoperatively.
3 of the 27 patients did not go home on the day of surgery because of nausea and/or diz-
ziness. The remaining 24 patients all went home on the day of surgery. PROMs improved 
substantially in these patients. Moreover, anchor questions on how patients functioned 
in their daily living indicated that the patients were satisfied with the postoperative 
results. 1 re-admission occurred at 11 days after surgery because of seroma formation. 
There were no other complications or reoperations.
In conclusion, at our hospital, with a fast-track protocol, outpatient THA was found to 
be feasible in selected patients with satisfying results up to 3 months postoperatively, 
without any outpatient procedure-specific complications or re-admissions.
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InTrOduCTIOn 
Traditionally, the length of hospital stay (LOS) after primary joint replacement has been 
more than several weeks.1 In the past few years, fast-track protocols have been intro-
duced worldwide. These protocols are based on principles of optimal clinical care and 
pain management in combination with a revision of organizational factors. This permits 
an optimized perioperative period in which patients can safely recover in a shorter pe-
riod of time.2,3 As a result of these improved factors, LOS has gradually been reduced.2-6
Reinier de Graaf Hospital (RdGG) is a large teaching hospital in the Netherlands. The 
introduction of a fast-track protocol for primary total hip arthroplasty (THA) started in 
2009 and was completed in 2011. After the implementation of this protocol for unselected 
patients, mean LOS decreased from 4.6 to 2.9 nights4 with a range of 1–7 nights. Since 
the LOS had been reduced, we wondered whether outpatient THA would be feasible at 
our hospital.
We therefore studied a selected group of patients who were treated for primary THA 
in an outpatient setting. We also investigated whether the postoperative results for this 
group of patients were satisfactory.
PATIenTs And MeTHOds
In this prospective cohort study, we included all the patients who were considered for 
primary THA in an outpatient setting between April and July, 2014. Patients had to have 
met the following criteria: ASA I or II; wanting to go home on the day of surgery; and 
sufficient support from a carer at home during the first postoperative day. Exclusion 
criteria were cardiovascular impairment and insulin-dependent diabetes mellitus.
All operations were performed by the same orthopedic surgeon (SV) through an 
anterior supine intermuscular approach. All the patients received uncemented prosthe-
ses (Taperloc femoral prosthesis and a Universal cup; both Biomet, Warsaw, IN). They 
were admitted on the day of surgery. The postoperative follow-up period was at least 3 
months.
Spinal anesthesia was by a low dose of bupivacaine (6–8 mg), to allow early mobiliza-
tion directly after surgery. The multimodal protocol for perioperative pain medication 
was standardized (Table).
Wounds were closed subcutaneously with Monocryl 3-0 (Ethicon, Somerville, NJ), 
after which 2 layers of Dermabond (Ethicon) were applied. The wound was then covered 
with a transparent dressing (Tegaderm; 3M, St. Paul, MN) to allow visual inspection of the 
wound. This dressing remained on the wound for 14 days, and allowed patients to take a 
shower immediately after surgery.
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Mean duration of surgery was 66 (47–81) min. Mean blood loss was 308 (0–650) mL and 
mean decrease in hemoglobin was 1.0 (0.5–2.1) g/dL.
The discharge criteria were functional: the patient had to be able to walk 30 m with 
crutches, to climb stairs, to dress independently, and to go to the toilet without help. 
In addition, sufficient pain treatment had to be achieved with oral medication before 
discharge, with VAS below 3 at rest and below 5 during mobilization. In addition, the 
wound had to be dry, patients could not be dizzy or nauseous, and hemoglobin levels 
should be higher than 9.7 g/dL. When a patient met all the discharge criteria, he/she had 
to make the final decision to go home or to spend a night in hospital.
EQ-5D increased from 0.71 (−0.04 to 0.96) preoperatively to 0.93 (0.68 to 1.00) at 6 weeks 
postoperatively and to 0.92 (0.44 to 1.00) at 3 months postoperatively. NRS for pain at 
Table: The standardized multimodal protocol for perioperative pain medication.
2 hours before surgery on the ward:
• Paracetamol (acetaminophen), 1000 mg per os.
• Celecoxib (Celebrex)A, 400 mg per os.
• Gabapentin, 600 mg per os.
Just before surgery:
• Dexamethasone, 0.15 mg/kg iv.B 
• Esketamine, 15 mg iv.
4 hours after surgery:
• Paracetamol (acetaminophen), 1000 mg per os.
8 hours after surgery:
• Paracetamol (acetaminophen), 1000 mg per os.
• Gabapentin, 300 mg per os.
Before the night:
• Oxicodone (OxyContin), 10 mg per os.
Day 1:
• Paracetamol (acetaminophen), 1000 mg per os 4 times a day.
• Celecoxib (Celebrex)A, 200 mg per os in the morning.
• Gabapentin, 300 mg per os in the morning.
After day 1:
• Paracetamol (acetaminophen), 1000 mg per os 4 times a day (with a maximum of 2 weeks).
• Celecoxib (Celebrex)A, 200 mg per os in the morning (until 2 weeks after surgery).
Rescue medication:
• Celecoxib (Celebrex)A, 200 mg per os extra after the first night.
• Piritramide (Dipidolor), 10 mg im, which could be repeated every 4 hours. 
A  In combination with celecoxib (Celebrex) all patients receive omeprazole, 20 mg per os once a day as prophylax-
is. When the patient is already using a proton pomp inhibitor before admission, no omeprazole is administered.
B  Dexamethasone solution in 50 mL saline is administered slowly to avoid adverse side affects such as severe 
perianal pain.
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rest decreased from 3.6 (1–8) preoperatively to 0.6 (0–3) at 6 weeks postoperatively and 
to 1.0 (0–10) at 3 months postoperatively. NRS for pain during activity decreased from 6.6 
(3–9) preoperatively to 1.4 (0–3) at 6 weeks postoperatively and to 1.9 (0–9) at 3 months 
postoperatively. All these changes were statistically significant (p < 0.001).
To score postoperative results, the patient-reported outcome measures (PROMs) EQ-
5D (mobility, self-care, usual activities, pain/discomfort, anxiety/depression)7,8 and the 
Numeric Rating Score (NRS) for pain at rest and during activity were recorded preopera-
tively and at 6 weeks and 3 months postoperatively.
Furthermore, anchor questions on how patients functioned in their daily living were 
scored at 6 weeks and 3 months postoperatively. The scoring of these questions varied 
from 1 (deteriorated very much since surgery) to 7 (improved very much since surgery). 
Anchor-based methods compare changes in scores on the instrument with an anchor, 
where the patients indicate whether they believe they are better than at baseline.9
Decrease in hemoglobin was defined as the hemoglobin level (g/dL) preoperatively 
minus the hemoglobin level just after surgery. All complications, re-admissions, and 
reoperations were registered and analyzed.
statistics
If data were normally distributed according to the Kolmogorov-Smirnoff test, they were 
analyzed using an independent Student t-test; otherwise, a Mann-Whitney test with a 
Bonferroni adjustment was performed. Any p-values less than 0.05 were considered to 
be significant. Data analysis was done with IBM SPSS Statistics for Mac, version 20.
resulTs
3 of the 27 patients stayed in hospital because of nausea and/or dizziness. The other 24 
patients went home on the day of surgery. In these 24 patients, mean age was 63 (48–71) 
years, 15 were women, mean BMI was 26 (20–33), and 15 patients were ASA I.
Mean duration of surgery was 66 (47–81) min. Mean blood loss was 308 (0–650) mL and 
mean decrease in hemoglobin was 1.0 (0.5–2.1) g/dL.
EQ-5D increased from 0.71 (−0.04 to 0.96) preoperatively to 0.93 (0.68 to 1.00) at 6 weeks 
postoperatively and to 0.92 (0.44 to 1.00) at 3 months postoperatively. NRS for pain at 
rest decreased from 3.6 (1–8) preoperatively to 0.6 (0–3) at 6 weeks postoperatively and 
to 1.0 (0–10) at 3 months postoperatively. NRS for pain during activity decreased from 6.6 
(3–9) preoperatively to 1.4 (0–3) at 6 weeks postoperatively and to 1.9 (0–9) at 3 months 
postoperatively. All these changes were statistically significant (p < 0.001).
Mean score for the anchor question on how patients functioned in their daily living 
was 6.2 at 6 weeks and 6.4 at 3 months (with 6 corresponding to much improvement 
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and 7 corresponding to very much improvement). There was 1 re-admission, 11 days after 
surgery, because of seroma formation. In addition, no complications or reoperations oc-
curred until 3 months postoperatively.
dIsCussIOn
To our knowledge, our hospital is the first in Europe to report on primary THA in an 
outpatient setting for a selected cohort of patients. In the USA, THA in an outpatient set-
ting for selected patients has already been described.1,10 Moreover, US centers have also 
reported on hemi- and total knee replacement in an outpatient setting.11,12 Although this 
trend in the USA could well be patient costdriven, as some patients have to pay extra for 
each night that they stay in hospital, there does appear to be a general trend towards 
outpatient joint replacement. These reports show that outpatient joint replacement is 
feasible in selected patients.
In the present study, 24 of the 27 selected patients who were scheduled to receive 
THA in an outpatient setting went home on the day of surgery. The PROMs improved 
significantly for these 24 patients. Moreover, the anchor question on how the patients 
functioned in their daily living indicated that they were satisfied with the postoperative 
results. Only 1 re-admission occurred at 11 days after surgery because of wound leakage, 
which was the result of seroma formation. This complication could occur in other set-
tings for THA, and it is therefore not likely to have been due to the outpatient setting. No 
surgery was performed in this particular case, and the wound healed otherwise without 
any further complication.
Why would one strive to perform joint replacement in an outpatient setting? An 
important reason might be hospital-acquired infection and the occurrence of multi-
resistant micro-organisms in hospital.13,14 An additional reason would be the lower costs 
associated with a shorter hospital stay.10
There might be concern about early loading of the implant during outpatient THA, 
especially with uncemented prostheses. However, no adverse effects of early full weight 
bearing of uncemented THAs have been described.15-17 Moreover, early loading of the 
THA is not unique to outpatient THA. It is an important part of fast-track surgery. In the 
fast-track protocol in our hospital, all patients are mobilized with immediate full weight 
bearing on the day of surgery.
In the current fast-track setting that we use in our hospital, patients are not selected. 
All patients are treated with the same protocol. As a part of the introduction protocol for 
new treatments at our hospital, we performed a prospective risk analysis. Several critical 
risk factors were identified. Based on these, patient selection criteria for the outpatient 
setting were established. We did not, however, want to introduce new traditions in or-
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thopedic practice that were not evidence-based,18 so we kept these criteria to the abso-
lute minimum, which we felt was necessary for the safe introduction of this protocol. The 
primary concerns after THA surgery were risk of cardiovascular incidents.19 Historically, 
this risk has been approximately 0.5%.20 This percentage has, however, been shown to 
decrease in a fast-track setting.5 Despite this reduced risk, we excluded patients with a 
history of cardiovascular disease from outpatient THA. In addition, we excluded patients 
with insulin-dependent diabetes mellitus.
Only patients with ASA I and II were scheduled for this outpatient setting, because 
higher ASA score is associated with increased risk of postoperative complications.21 Fur-
thermore, increased ASA score has been described as a predictor of prolonged hospital 
stay,22-25 which could be explained by the association of ASA score with comorbidities. In 
our fast-track setting, however, there was no effect of ASA score on LOS in a multivariate 
logistic regression model, confirming the results of den Hartog et al.26
The final selection criterion in this study was practical. Patients had to have sufficient 
support from a carer at home during the first postoperative night. Younger patients are 
more likely to have sufficient support at home (from cohabitants) than older people. 
Possibly as a result of this, the mean age of the patients in the present study was 63 
years, which is less than the mean age of patients whom many surgeons see. Both 
younger age and living together with cohabitants have been found to be associated 
with shortened LOS.26
In addition to the selection criteria, as a result of the prospective risk analysis 3 dis-
charge criteria were added to the standard fast-track discharge list. The most important 
of these was that patients wanted to go home on the day of surgery. After the orthopedic 
surgeon approved the discharge, the patient made the final decision to leave the hos-
pital. If patients were not feeling comfortable with the idea of going home, they stayed 
in hospital. This was the case with one patient. She had been dizzy and nauseous during 
the day, but was fit to go home at the end of the afternoon. She preferred to spend a 
night in the hospital, however, and left the following morning after an uneventful night.
Dizziness, nausea, and vomiting, which continued during the afternoon of the day of 
surgery were also introduced as a discharge criterion. 2 patients were not allowed to 
leave the hospital because of this, one of whom (a patient aged 77) ended up spend-
ing 2 nights in hospital. Orthostatic intolerance and nausea and vomiting are likely to 
be caused by either the pain management or the surgery.2 The challenge remains to 
optimize perioperative care even further to prevent the occurrence of these side effects.
Persistent wound leakage was also a reason not to discharge patients. With our 
wound-care protocol, all the patients had a (nearly) dry wound at discharge and no ad-
ditional leakage occurred during the first night at home.
The final selection criterion in this study was practical. Patients had to have sufficient 
support from a carer at home during the first postoperative night. Younger patients are 
38 Chapter 3 
3
more likely to have sufficient support at home (from cohabitants) than older people. 
Possibly as a result of this, the mean age of the patients in the present study was 63 
years, which is less than the mean age of patients whom many surgeons see. Both 
younger age and living together with cohabitants have been found to be associated 
with shortened LOS.26
Finally, a hemoglobin level of higher than 9.7 g/dL was introduced as a discharge crite-
rion. In patients without a history of cardiovascular disease, this is a relatively high level, 
which leaves room for a further drop in the days after surgery. The lowest postoperative 
hemoglobin level measured was 10.5 g/dL.
Since we studied a selected cohort of THA patients, we could not compare the results 
of our study population to the results of our total THA patient population. The set-up of a 
prospective randomized clinical trial would provide more information when comparing 
postoperative results between outpatient THA and inpatient THA in a fast-track setting.
In conclusion, at our hospital, with a fast-track protocol and using the anterior supine 
intermuscular approach, outpatient THA is feasible in selected patients and can give sat-
isfactory results up to 3 months postoperatively without outpatient procedure-specific 
complications or re-admissions.
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AbsTrACT
After implementation of a ‘fast-track’ rehabilitation protocol in our hospital, mean length 
of hospital stay for primary total hip arthroplasty decreased from 4.6 to 2.9 nights for 
unselected patients. However, despite this reduction there is still a wide range across 
the patients’ hospital duration. The purpose of this study was to identify which specific 
patient characteristics influence length of stay after successful implementation of a ‘fast-
track’ rehabilitation protocol. A total of 477 patients (317 female and 160 male, mean age 
71.0 years; 39.3 to 92.6, mean BMI 27.0 kg/m2; 18.8 to 45.2) who underwent primary total 
hip arthroplasty procedure 1 February 2011 and 31 January 2013, were included in this 
retrospective cohort study. A length of stay greater than the median was considered as 
an increased duration. Logistic regression analyses were performed to identify potential 
factors associated with increased durations. Median length of stay was two nights (in-
terquartile range 1), and the mean length of stay 2.9 nights (1 to 75). In all, 266 patients 
had a length of stay ≤ two nights. Age (odds ratio (OR) 2.46; 95% confidence intervals (CI) 
1.72 to 3.51; p < 0.001), living situation (alone vs living together with cohabitants, OR 2.09; 
95% CI 1.33 to 3.30; p = 0.002) and approach (anterior approach vs lateral, OR 0.29; 95% CI 
0.19 to 0.46; p < 0.001) (posterolateral approach vs lateral, OR 0.24; 95% CI 0.10 to 0.55; p 
< 0.001) were factors that were significantly associated with increased length of stay in 
the multivariable logistic regression model.
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InTrOduCTIOn 
Length of stay (LOS) after total hip arthroplasty (THA) has reduced in recent years fol-
lowing the introduction of ‘fast-track’ rehabilitation protocols in both selected and un-
selected patients.1-5 These studies have demonstrated reduction of LOS and rapid early 
rehabilitation can be undertaken safely without affecting outcomes. These protocols are 
based on analysis of core care principles and effective pain management and efficient 
organisation, allowing an optimised and safe peri-operative care.1-5
The Reinier de Graaf Hospital (RdGG) in the Netherlands is a large teaching hospital 
which introduced ‘fast-track’ rehabilitation for primary THA progressively from 2009. 
Introduction was incremental and was complete by February 2011. After the implemen-
tation of this ‘fast-track’ rehabilitation protocol, the mean LOS for primary THA had de-
creased from 4.6 to 2.9 nights for unselected patients in our hospital.5 However, despite 
the mean reduction in LOS, there was still a wide range. Previous studies have shown 
that patient and provider characteristics could affect LOS after primary THA.6-10 However, 
most of these studies were not performed in a ‘fast-track’ setting.8-10 Early preoperative 
identification of patients who need extended rehabilitation time and enhanced care 
might provide further optimisation of discharge and rehabilitation planning. Therefore, 
the goal of this study was to identify specific patient characteristics which influence LOS 
using ‘fast-track’ rehabilitation principles in our institution. 
PATIenTs And MeTHOds 
We conducted a retrospective cohort study of all 477 patients undergoing primary THA 
at RdGG between 1 February 2011 and 31 January 2013. All procedures were performed in 
a ‘fast-track’ setting. There were no exclusion criteria. 
The surgery was undertaken by ten experienced surgeons, each with a minimum of 
50 previous THAs prior to the start of the study. Surgical approach was according to 
the surgeon’s preference. Patients were not assigned to a particular approach. Various 
surgical approaches were used: the anterior supine intermuscular (ASI) approach11,12 the 
straight lateral (SL) approach13,14 and the posterolateral (PL) approach.15,16
The discharge criteria were functionally based. Patients were required to be able to 
walk 30 metres with crutches, climb stairs, get dressed independently and to be able to 
go to the lavatory independently. In addition, adequate pain relief had to be achieved 
with oral medication before discharge, with a visual analogue score (VAS, 0 to 10,best to 
worst) < 3 at rest and < 5 during mobilisation.
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The primary outcome measure was LOS, which was defined as the number of nights 
spent in hospital. LOS was divided into two groups, determined by the median value; a 
LOS greater than the median was considered to be an increased LOS. 
Potential factors associated with an increased hospital stay were obtained from case 
note analysis. Factors include age, living situation, anaesthesia, approach, gender, body 
mass index (BMI), American Society of Anaesthesiologists (ASA) classification17 and 
mobility-limiting comorbidities.
BMI was categorised into three groups according to the criteria of the World Health 
Organization:18 normal weight (18.5 kg/m2 to 25 kg/m2), overweight (25 kg/m2 to 30 kg/
m2) and obese (≥30 kg/m2). ASA classification was categorised into: ASA I, ASA II and 
ASA III/IV. 
To investigate the effect of mobility-limiting co-morbidities on LOS, two reviewers 
(YH, SV) independently assessed if specific co-morbidities reported in the case notes 
could potentially influence patient mobility. Rheumatoid arthritis; neurologic disorders 
(e.g. lumbar disc prolapse, multiple sclerosis, Parkinson’s disease and paralysis after cere-
bral vascular accident); as well as osteoarthritis of the contralateral leg and/or adjacent 
joint were scored to be mobility-limiting. Disagreements in assessments were solved by 
consensus, and a final decision of a third reviewer (NM) was not required. 
statistical analysis 
The associations between each variable and LOS were examined with univariate logistic 
regression analyses. Predictors that were associated with the outcome in univariate 
analyses (p-values < 0.15) were included in multivariable logistic regression analyses. In 
multivariable logistic regression analyses p-values < 0.05 were considered significant. 
Data analyses were conducted using R version 3.0.2 with package ‘rms’.19,20
resulTs 
The mean LOS for the group as a whole (n = 477) was 2.9 nights (1 to 75) with a median of 
two nights (interquartile range (IQR 1). From the total of 477 patients, 266 patients had a 
LOS ≤ two nights and 211 a LOS > two nights. The large range in LOS was influenced by 
two patients. One of them had a LOS of 24 nights due to a prolonged state of confusion, 
the other had a LOS of 75 nights due to deep infection of their THA. Excluding these two 
outliers, LOS of the other 475 patients ranged between one and ten nights.
The mean age was 71.0 years (39.3 to 92.6) and mean BMI was 27.0 kg/m2 (18.8 to 45.2). 
Most patients (31; 66.5%) were female. The most common surgical approach was the ASI 
approach, used in 265 patients (55.6%). The SL approach was used in 176 patients (36.9%) 
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Table 1: Demographic data for 477 patients undergoing total hip arthroplasty (THA), for the group with a 
length of hospital stay ≤ two nights, and for the group with a length of hospital stay of > two nights. 
Total
n (%)
≤ 2 nights
n (%)
> 2 nights
n (%)
n = 477 n = 266 n = 211
Age (years) 71.0 (9.9)* 67.7 (9.2)* 75.2 (9.1)*
Anaesthesia Spinal 447 (93.7) 246 (92.5) 201 (95.3)
Approach ASI 265 (55.6) 183 (68.8) 82 (38.9)
Straight Lateral 176 (36.9) 58 (21.8) 118 (55.9)
Posterolateral 36 (7.5) 25 (9.4) 11 (5.2)
Gender Female 317 (66.5) 159 (59.8) 158 (74.9)
BMI (kg/m2) 18.5 to 25 167 (35.0) 85 (32.0) 82 (38.9)
25 to 30 213 (44.7) 134 (50.4) 79 (37.4)
≥ 30 97 (20.3) 47 (17.6) 50 (23.7)
ASA score I
II
III/IV
100 (21)
318 (66.7)
59 (12.3)
72 (27.1)
174 (65.4)
20 (7.5)
28 (13.3)
144 (68.2)
39 (18.5)
Living situation Alone 169 (35.4) 62 (23.3) 107 (50.7)
Mobility-limiting 
comorbidity
Yes 93 (19.5) 54 (20.2) 39 (18.5)
*mean (standard deviation (SD)) 
Table 2: Results of univariate and multivariate logistic regression for potential factors associated with a 
prolonged hospital stay.
Characteristic Univariate Analyses Multivariate Analyses
OR (95% CI) p-value OR (95% CI) p-value
Age (yrs) 3.55 (2.58 - 4.88)* <0.001 2.46 (1.72 - 3.51)* <0.001
Living situation Alone 3.39 (2.29 – 5.01) <0.001 2.09 (1.33-3.30) 0.002
Anaesthesia General 0.61 (0.28-1.34) 0.2 - -
Approach - <0.001 - <0.001
  vs. SL ASI 0.22 (0.15 – 0.33) <0.001 0.29 (0.19 – 0.46) <0.001
PL 0.22 (0.10 – 0.47) <0.001 0.24 (0.10 – 0.55) <0.001
Gender Male 0.5 (0.34 - 0.74) <0.001 0.72 (0.45 - 1.15) 0.2
BMI (kg/m2) - 0.02 - 0.4
  vs. 18.5-25 25 to 30 0.61 (0.40 – 0.92) 0.02 0.75 (0.47 - 1.21) 0.2
 ≥ 30 1.10 (0.67 - 1.82) 0.7 1.02 (0.56 - 1.85) 0.9
ASA - <0.001 - 0.4
  vs. I II 2.13 (1.30 – 3.47) 0.004 1.26 (0.71 -2.23) 0.4
III/IV 5.01 (2.51 – 10.03) <0.001 1.72 (0.76 – 3.91) 0.2
Mobility-limiting 
comorbidity
Yes 0.89 (0.56 – 1.41) 0.6 - -
Overall multivariate model fit: LR χ2(9 representing df)=131.89, p <0.001)
LR, likelihood ratio;  χ2, chi squared; df, degrees of freedom
*inter-quartile odds ratio (OR) (78.3 vs 64.4). 
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and the PL approach was used in 36 patients (7.5%). Most patients (447;93.7%) received 
spinal anaesthesia (Table 1).
Results of univariate and multivariable logistic regression analyses are presented in 
Table 2. Age (odds ration (OR) 2.46; 95% confidence intervals (CI) 1.72 to 3.51; p < 0.001), 
living situation (alone vs living together with cohabitants, OR 2.09; 95% CI 1.33 to 3.30; p 
= 0.002) and approach (ASI approach vs SL, OR 0.29; 95% CI 0.19 to 0.46; p < 0.001; PL ap-
proach vs SL, OR 0.24; 95%CI 0.10 to 0.55); p < 0.001) were factors that were significantly 
associated with increased LOS in a multivariable logistic regression model (Table 2). No 
difference in LOS was found comparing the ASI with the PL approach (ASI approach vs 
PL, OR 1.25; 95% CI 0.54 to 2.85; p = 0.604).
dIsCussIOn 
The aim of this study was to identify any patient-specific characteristics influencing the 
LOS after the successful implementation of a ‘fast-track’ rehabilitation protocol. Age, 
living situation and surgical approach were associated with a significantly increased LOS 
over the median after primary THA in 477 unselected patients in our institution. 
There is a growing interest in introducing ‘fast-track’ rehabilitation protocols with the 
aim of reducing LOS.1-5 For the purposes of our study, more than two nights in hospital 
was considered an increased LOS. Many other studies investigating prolonged LOS have 
not used ‘fast-track’ rehabilitation and LOS greater than ten days was considered to be 
‘prolonged’.8-10,21-23 
Living alone was associated with an increased LOS in our study, which is in accordance 
with other studies.6,7 Although not investigated specifically in our study, marital status 
has been said elsewhere to have no influence on LOS.9 However, this does necessarily 
correlate with the amount of assistance a patient can obtain after discharge as family or 
relatives might be able to provide assistance after discharge. 
Other studies have identified older age as a predictor for increased hospital stay.6-9,22 
This can be explained by the association of increased age and co-morbidities with 
greater care needs after discharge. Our results confirm this association.
The influence of surgical approach on recovery and LOS after primary THA is open 
to debate. Our study demonstrated a significant difference on LOS, in favour of both 
the ASI and PL approaches compared with the SL approach. No difference in LOS was 
found comparing the ASI with the PL approach. Previously published studies have 
demonstrated that patients operated on using the anterior approach have a shorter LOS 
compared with that of a lateral approach.24-26 Authors have suggested that using the 
muscle-splitting interval used for the anterior approach facilitates early recovery due 
to less muscle damage.11,14,27-29 Other studies have also not demonstrated a difference 
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in LOS comparing the anterior or the posterior surgical approaches, as in our study.30-31 
Contrary to our results, other investigations have not shown differences LOS between 
the anterior and lateral approaches.23 The nature and characteristics of these different 
studies are very variable, regarding the number of patients studied, randomisation and 
pro- or retrospective studied cohort. Furthermore, the experience of the surgeon with 
the studied surgical approaches and the potential presence of a ‘learning curve’ might 
explain some of the differences of the effect of surgical approach on LOS.23,30-34 The 
definition of a ‘learning curve’ for THA procedures has been suggested to be 20 cases 
but this is contentious.35 In our study all procedures were performed by experienced 
hip surgeons who performed more than 50 procedures before the start of this study, in 
order to overcome potential effects of limited surgical experience or the ‘learning curve’. 
In a systematic review, no difference between regional and systemic analgesia on LOS 
after THA has been found.36 This is supported by our study, though the data was skewed 
with 477 of our patients (94%) having regional anaesthesia. Fast-track protocols favour 
spinal anaesthesia above general anaesthesia because of the potential side effects of 
the latter. These side effects might cause prolonged rehabilitation and therefore an 
increased LOS.1-4,37 
Female gender has been reported to be associated with an increased hospital 
stay.6,8,22,38,39 None of these studies give a clear explanation for their findings, except for 
the possibility of lower limb strength in women.22 Our study demonstrated no effect of 
gender on LOS. 
Obesity has been shown to be associated with a slower postoperative recovery10 and 
an increased LOS.21-40 Furthermore, patients with a greater body weight might be ex-
pected to have more problems mobilising after surgery22 and therefore be expected to 
have an increased LOS after surgery, since the discharge criteria are mostly functional. 
However, our study demonstrated no effect of BMI on LOS. Other studies have similarly 
not shown an adverse effect of increased BMI on LOS.6,10,23,38,41 Moreover, two other stud-
ies investigating the effect of BMI on LOS and perioperative complications after both 
THA and total knee arthroplasty also demonstrated no adverse effect of BMI.9,42 
Increased ASA score has been described as a predictor for increased hospital 
stay.6,10,23,38 This has been explained by the association of ASA score with co-morbidities. 
However, our study demonstrated no effect of ASA score on LOS after adjusting for other 
variables in the model. The lack of measurable effect of ASA on LOS might be influenced 
by our definition of increased LOS (> two nights) used in our study.
Furthermore, ASA score provides limited information regarding specific co-morbidities, 
in particular ‘mobility limiting’ co-morbidities. These co-morbidities might be associated 
with increased LOS. Therefore, we added ‘mobility limiting’ co-morbidities as potential 
factors associated with an increased hospital stay to our model. Our study demonstrated 
no effect of ‘mobility limiting’ co-morbidities on LOS.
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The effect of type of fixation of the prosthesis has previously been investigated as a 
potential predictor for LOS,10,23 but did not include this variable in our study as the type 
of fixation was guided by age of the patient in our hospital. Operating time,23,38 smoking 
status,6 peri-operative blood loss,23,38 and the effect of different co-morbidities9,21 have 
also been studied and appeared to have no influence on LOS.
Our study has some potential limitations. First, we divided our study group into two 
as defined by the median LOS of two nights. In the absence of a pre-determined cut off 
point, the most common approach is to take the sample median.43 Using the sample 
median implies that various cut off points will be used in different studies so that results 
might be difficult to compare. In addition, much information is lost (e.g. every value 
above the median is considered equal), so the statistical power to detect a relation might 
be reduced.43 However, we do not believe this to be a problem in the present study. 
Second, a prospective study might have provided us with additional information to 
predict the LOS better, e.g. preoperative patient-reported outcome measures (PROMs), 
compared with the retrospective nature in the present study. We could not include 
PROMs in our analysis, as the PROMs data were recorded inconsistently within the case 
notes of the patients. However, this retrospective cohort study included all 477 patients 
who underwent primary THA after the successful implementation of fast-track rehabili-
tation in our hospital without any pre-determined selection criteria or bias. 
Third, according to the International Classification of adult underweight (<18.5 kg/
m2), normal weight (18.5 kg/m2 to 25 kg/m2), overweight (25 kg/m2 to 30 kg/m2) and 
obese (>30 kg/m2) according to BMI as used by the World Health Organization, patients 
included in our study were either of normal weight (35.0%), overweight (44.7%) or obese 
(20.3%). Although we think that the patients in our study are a good representation of 
the BMI range within the Dutch population, the case mix of the orthopaedic surgeons in 
other countries might differ.
Finally, it should be noted that few surgeons currently routinely use the ASI approach. 
In our study a majority of patients (55.6%) underwent operation using the ASI approach. 
The remainder of the patients underwent operation using the more commonly used SL 
and PL approach, allowing for our findings to inform most hip surgeons’ practice.
In conclusion, older age, living alone and the lateral surgical approach were associ-
ated with a prolonged LOS after primary THA in a ‘fast-track’ setting for 477 unselected 
patients. This knowledge allows further optimisation of discharge and rehabilitation 
planning for patients with these characteristics.
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AbsTrACT
There is still discussion about possible advantages and disadvantages of the less invasive 
anterior approach for total hip arthroplasty (THA). The purpose of our systematic review 
was to evaluate literature regarding the anterior approach in comparison to other ap-
proaches. Furthermore, we investigated if there is a description of a learning curve for 
the anterior approach.
Data were obtained from EMBASE, Cochrane, PsychINFO, CINAHL, Web-of-Science, 
Scopus, Google scholar, and PubMed since their inception up to June 2015. 2 reviewers 
independently selected the studies and independently conducted the quality assess-
ment. Because studies were considered heterogeneous regarding outcome measures, 
determinants studied, and methodological quality, we decided to perform a “best 
evidence synthesis”. A total of 64 studies met the inclusion criteria.
Strong evidence for no difference in component placement between the anterior ap-
proach and other approaches was found. Also, strong evidence for faster postoperative 
recovery and less need for assistive devices after the anterior approach were found. All 
other studied parameters only demonstrated conflicting evidence. Although the learn-
ing curve for the anterior approach is not yet clear, this learning curve should not be 
neglected. 
In conclusion, the less invasive anterior approach provides benefits in the early postop-
erative period only, when compared to other approaches.
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InTrOduCTIOn
The less invasive anterior approach for total hip arthroplasty (THA) was first performed 
by Robert Judet in 1947.1 Both intermuscular and internervous planes are used for this 
approach and several advantages have been described in literature.1-15 However this ap-
proach has its own unique set of complications and is sometimes criticized because of 
its technical difficulty.6,11-13,16-21 Many publications demonstrated that extensive training 
is necessary, even for experienced surgeons to perform this technique and surgeons 
considering this approach should expect a substantial learning period.1,6,8,19
Recently Moskal et al.22 wrote a review about the anterior muscle sparing approach 
with a fracture table for THA, considering complication rate, component placement and 
the learning curve. However, their article is not a systematic review, it is limited to the 
use of a fracture table and therefore it does not reflect all available literature on this 
subject. Hence, a clear overview about the anterior approach with a quality assessment 
and a best evidence synthesis is missing in literature.
The purpose of our systematic review was to evaluate the literature regarding advan-
tages as well as disadvantages for the less invasive anterior approach for primary THA 
in comparison to other approaches for perioperative as well as postoperative aspects. 
First, we hypothesized that patients operated through the anterior approach recover 
faster and experience less postoperative pain in comparison to other approaches, since 
muscle attachments are preserved. Second, we hypothesized that there are no other dif-
ferences in outcome parameters between the anterior approach and other approaches. 
Third, we wanted to investigate if there is a clear description of the learning curve for 
the anterior approach.
MeTHOds
data sources and searches
We performed a search for relevant studies in EMBASE, Cochrane, PsychINFO, CINAHL, 
Web-of-Science, Scopus, Google scholar, and PubMed since their inception up to June 
30, 2015. Search terms included the anterior approach, THA, complication rate, recovery 
time, component placement and learning curve. The full electronic search strategy for 
the EMBASE database is presented in Table 1.
Additionally, citation tracking was performed by manually screening the reference 
lists of eligible studies by 1 reviewer (YH).
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Table 1: Full electronic search strategy for the EMBASE database.
(‘total hip prosthesis’/exp OR ‘hip prosthesis’/de OR ‘hip arthroplasty’/de OR (((hip) NEAR/3 (arthroplast* 
OR prosthe* OR replace* OR endoprosthes*)) OR THA OR THR OR THAs OR THRs):ab,ti) AND (‘surgical ap-
proach’/de OR (((surgical* OR anterior OR hueter*) NEAR/6 (approach* OR route*))):ab,ti)
study selection
2 reviewers (YH, NM) assessed the studies on whether they met the following inclusion 
criteria:
•	 Patients in the study underwent primary THA for osteoarthritis;
•	 The anterior approach was used;
•	 The study described an adequate follow up period;
•	 Both prospective and retrospective studies were included;
•	 The study described perioperative and/or postoperative parameters in comparison 
to another approach and/or described the learning curve for the anterior approach;
•	 Original data were available (no (systematic) review or meta-analaysis);
•	 The article was written in English.
Disagreement on inclusion was resolved by discussion, and a final decision of a third 
reviewer (SV) was not necessary.
Quality assessment
The methodological quality of observational studies can vary, which might influence the 
results and conclusions of these studies, and subsequently, the results and conclusions 
of a systematic review.
We scored the internal validity of the selected studies using eight questions from 
existing quality assessment tools.23-25
The following questions were used:
1. Inclusion of consecutive patients?
2. Description of in- and exclusion criteria?
3.  Did the authors report the participation rate and did patients give informed 
consent?
4. Unbiased assessment of outcome and determinant?
5. Was the follow-up period appropriate?
6. Did they report a loss to follow-up less than 20%?
7. Is there any information about the sample size calculation?
8. Were statistical tests appropriate and did they adjust for cofounders?
2 reviewers (YH, NM) assessed the quality independently. Disagreements were solved by 
discussion, and a final decision of a third reviewer (SV) was not necessary.
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Studies were classified as high quality when they scored ≥ 5 points and when mini-
mally question 1, 4 and 8 were scored as “yes”.23-25
data extraction
1 reviewer (YH) extracted study characteristics and outcome determinants. The different 
aspects of primary THA that were analyzed were both perioperative and postoperative: 
surgery time, incision length, blood loss, complication rate, length of hospital stay (LOS), 
postoperative pain and pain medication consumption, questionnaire scores, accuracy of 
component placement checked by postoperative x-rays, and functional recovery.
best evidence synthesis
Because the studies were considered heterogeneous with regard to outcome measures, 
determinants studied, and methodological quality, we decided not to pool data and to 
perform a “best evidence synthesis”.26,27
The following ranking of levels of evidence was formulated26,27:
•	 Strong evidence is provided by 2 or more studies with high quality and by generally 
consistent findings in all studies (≥75% of the studies reported consistent findings);
•	 Moderate evidence is provided by 1 high quality study and 2 or more low-quality 
studies and by generally consistent findings in all studies (≥75%);
•	 Limited evidence is provided by low-quality studies or 1 high-quality study an by 
generally consistent findings (≥75%);
•	 Conflicting evidence is provided by conflicting findings (<75% of the studies reported 
consistent findings);
•	 No evidence is provided when no studies could be found.
resulTs
Identification and selection of literature
The search resulted in 2,528 articles of which the abstracts were reviewed. Screening of 
the titles and abstracts resulted in 365 possibly relevant studies. Of these studies the 
full text articles were reviewed and 64 studies were included. Reasons for exclusion 
are presented in the flow chart of the study selection (Figure 1). Citation tracking was 
performed by manually screening the reference lists of eligible studies and additionally 
no other study was identified as possibly relevant.
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description of included studies
Table 2 presents the characteristics of the included studies. 21 prospective and 43 retro-
spective studies were included. A total of 50 studies compared the anterior to another 
approach. Of these 50 studies, only 9 studies were randomized (18%), the remaining 41 
studies were nonrandomized (82%). All together these 50 comparative studies involve 
5,691 patients operated by anterior approach. The randomized group numbers 346 
figure 1: Flow chart of the study selection according to PRISMA-statement.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching 
(n=3545) 
Additional records identified 
through other sources 
(n=0) 
Records after removal of 
duplicates 
(n=2528) 
Records screened 
(n=2528) 
Full text articles assessed 
for eligibility 
(n=365) 
Studies included in qualitative 
synthesis (n=64) 
 
Prospective  (n=21) 
Retrospective (n=43) 
Records excluded 
(n=2163) 
Full text articles excluded (n=301) 
 
- Article not written in English or Dutch (n=35) 
- No original data available (n=87) 
- No description of the anterior approach (n=64) 
- No separate data for the anterior approach (n=44) 
- No primary THA for osteoarthritis (n=11) 
- Not comparing the anterior approach to another 
approach or not describing the learning curve 
(n=42) 
- No access to the article (n=15) 
- Article withdrawn (n=3) 
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patients (6.1%) and the nonrandomized group 5,345 patients (93.9%). The remaining 14 
studies described solely the results of the anterior approach. These 14 studies involve 
3,796 patients.
21 studies described or investigated the effect of a learning curve. Furthermore 30 
studies described the results of the first THAs performed through the anterior approach. 
18 studies did not mention the experience of the surgeon performing surgery with the 
anterior approach. Another 16 studies described the number of THAs performed through 
the anterior approach by the surgeon before the start of the study, or simply mentioned 
that the surgeon was experienced with the anterior approach. Follow up time in se-
lected studies differed from several days up to 5 years. Regarding type of surgery table, a 
standard surgery table was used in 28 studies and 25 studies mentioned to use a fracture 
table. 11 studies did not mention the used kind of surgery table in their study. A total of 
22 studies mentioned to use perioperative fluoroscopy for the anterior approach and 4 
studies used perioperative navigation for component placement.
A total of 14 studies did not report information regarding the types of osteoarthritis, 37 
studies provided information about the included types of osteoarthritis and 31 provided 
information about the excluded types of osteoarthritis in their study. Of these studies, 
18 reported on both included and excluded types of osteoarthritis.
Quality assessment
The results of the quality assessment are presented in Table 3. A total of 23 studies were 
qualified as “high quality” and 41 studies were qualified as “low quality”. In only 7 studies, 
a sample size calculation was presented.
Postoperative component placement
Postoperative component placement was measured regarding cup anteversion, cup 
inclination, femoral component alignment, and/or leg length discrepancy (LLD).
A total of 23 studies compared these results of the anterior approach to the anterolat-
eral, lateral, or posterior approach, with strong evidence that there was no difference in 
postoperative component placement between the anterior approach and the different 
approaches9,11,20,30,32-34,36,37,39-44,69,74-76,78-80,82 (Table 4). Of these studies only 9 reported on 
perioperative use of fluoroscopy34,36,42,44,74,75,78,79,82 and 3 on perioperative use of naviga-
tion for component placement.37,40,76 The only study demonstrating results against the 
anterior approach, was a study describing the first THAs performed through the anterior 
approach.11
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Table 3: Quality assessment.
Study 1 2 3 4 5 6 7 8 Total Quality
Christensen et al. 2015 (72) Prospective 1 1 1 1 0 1 1 1 7 High quality
Goytia et al. 2012 (48) Prospective 1 1 0 1 1 1 0 1 6 High quality
Mjaaland et al. 2015 (77) Prospective 1 1 1 1 0 0 0 1 5 High quality
Morris et al. 2013 (62) Prospective 1 1 1 1 1 0 0 1 6 High quality
Rathod et al. 2014 (66) Prospective 1 1 1 1 1 0 0 1 6 High quality
Restrepo et al. 2010 (67) Prospective 1 1 1 1 1 0 1 1 7 High quality
Rodriquez et al. 2014 (34) Prospective 1 1 1 1 0 0 1 1 6 High quality
Sendtner et al. 2010 (30) Prospective 1 1 0 1 1 1 0 1 6 High quality
Taunton et al. (82) Prospective 1 1 1 1 1 1 0 1 7 High quality
Bhargava et al. 2010 (17) Retrospective 1 1 0 1 1 0 0 1 5 High quality
Bremer et al. 2011 (60) Retrospective 1 1 1 1 1 0 0 1 6 High quality
De Geest et al. 2013 (49) Retrospective 1 0 1 1 1 1 0 1 6 High quality
Hallert et al. 2012 (19) Retrospective 1 1 0 1 1 0 0 1 5 High quality
den Hartog et al. 2015 (73) Retrospective 1 1 0 1 0 1 0 1 5 High quality
Martin et al. 2013 (36) Retrospective 1 1 0 1 0 1 0 1 5 High quality
Melman et al. 2015 (83) Retrospective 1 1 0 1 1 0 0 1 5 High quality
Muller et al. 2014 (84) Retrospective 1 1 1 1 1 1 0 1 7 High quality
Poehling et al. 2014 (78) Retrospective 1 1 0 1 0 1 0 1 5 High quality
Rathod et al. 2014 (79) Retrospective 1 1 0 1 1 0 0 1 5 High quality
Reichert et al. 2015 (80) Retrospective 1 1 0 1 1 0 0 1 5 High quality
Sheth et al. 2015 (81) Retrospective 1 1 0 1 1 1 1 1 7 High quality
Spaans et al. 2012 (20) Retrospective 1 1 0 1 1 0 0 1 5 High quality
Sugano et al. 2009 (37) Retrospective 1 0 0 1 1 1 0 1 5 High quality
Barrett et al. 2013 (38) Prospective 0 1 1 1 1 0 1 1 6 Low quality
Bergin et al. 2011 (39) Prospective 0 1 0 1 0 0 1 1 4 Low quality
D’Arrigo et al. 2009 (28) Prospective 0 1 1 1 0 0 0 1 4 Low quality
Hananouchi et al. 2009 
(40) Prospective 1 0 1 1 0 0 0 1 4
Low quality
Hozack et al. 2008 (31) Prospective 0 0 0 1 0 0 0 0 1 Low quality
Ilchmann et al. 2013 (42) Prospective 1 1 1 0 1 1 0 1 6 Low quality
Klausmeier et al. 2010 (59) Prospective 0 1 1 1 0 0 0 1 4 Low quality
Lugade et al. 2010 (64) Prospective 0 0 1 1 0 0 0 1 3 Low quality
Mayr et al. 2009 (43) Prospective 0 1 1 1 0 0 0 1 4 Low quality
Pilot et al. 2006 (56) Prospective 0 0 1 1 0 0 0 1 3 Low quality
Reininga et al. 2013 (57) Prospective 0 1 1 1 0 0 0 1 4 Low quality
Ward et al. 2008 (58) Prospective 0 0 1 1 0 0 0 1 3 Low quality
Abe et al. 2015 (69) Retrospective 0 1 0 1 0 0 0 1 4 Low quality
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Table 3: Quality assessment. (continued)
Study 1 2 3 4 5 6 7 8 Total Quality
Alecci et al. 2011 (15) Retrospective 1 0 1 1 0 0 0 1 4 Low quality
Alexandrov et al. 2014 (70) Retrospective 1 1 0 1 1 0 0 0 4 Low quality
Baba et al. 2014 (29) Retrospective 0 0 0 1 1 0 0 1 3 Low quality
Berend et al. 2009 (8) Retrospective 1 0 0 1 0 0 0 0 2 Low quality
Bhandari et al. 2009 (1) Retrospective 0 1 0 1 0 0 1 1 4 Low quality
Christensen 2014 (71) Retrospective 1 1 0 1 0 0 0 1 4 Low quality
Goebel et al. 2012 (45) Retrospective 1 1 0 1 0 0 0 1 4 Low quality
Hamilton et al. 2015 (74) Retrospective 1 0 0 1 0 0 0 0 2 Low quality
Jewett et al. 2011 (18) Retrospective 1 0 0 1 1 1 0 0 4 Low quality
Ji et al. 2015 (75) Retrospective 1 1 0 1 0 0 0 1 4 Low quality
Lamontagne et al. 2011 
(61) Retrospective 0 1 1 1 0 0 0 1 4
Low quality
Maeda et al. 2015 (76) Retrospective 0 0 0 1 0 0 0 1 2 Low quality
Maffiuletti et al. 2009 (41) Retrospective 0 1 1 1 0 0 0 1 4 Low quality
Mantovani et al. 2012 (63) Retrospective 0 0 1 1 0 0 0 1 3 Low quality
Masonis et al. 2008 (50) Retrospective 1 1 0 1 0 0 0 1 4 Low quality
Nakata et al. 2009 (9) Retrospective 1 1 0 1 0 0 0 1 4 Low quality
Nam et al. 2013 (44) Retrospective 1 1 0 1 0 0 0 1 4 Low quality
Oinuma et al. 2007 (47) Retrospective 1 1 0 1 0 0 0 0 3 Low quality
Parvizi et al. 2013 (65) Retrospective 1 1 0 1 0 0 0 1 3 Low quality
Pogliacomi et al. 2012 (32) Retrospective 0 1 0 1 1 0 0 1 4 Low quality
Pogliacomi et al. 2012 (33) Retrospective 0 1 0 1 1 0 0 1 4 Low quality
Sebečić et al. 2012 (35) Retrospective 0 0 0 1 0 0 0 0 1 Low quality
Seng et al. 2009 (10) Retrospective 1 0 0 1 0 0 0 0 2 Low quality
Varin et al. 2013 (68) Retrospective 0 1 1 1 0 0 0 1 4 Low quality
Wayne et al. 2009 (11) Retrospective 1 1 0 1 0 0 0 1 4 Low quality
Woolson et al. 2009 (12) Retrospective 1 0 0 1 0 0 0 0 2 Low quality
Yi et al. 2013 (21) Retrospective 1 0 0 1 0 0 0 0 2 Low quality
Zawadsky et al. 2014 (46) Retrospective 1 0 0 1 0 1 0 1 4 Low quality
1. Inclusion of consecutive patients?
2. Description of in- and exclusion criteria?
3. Did the authors report the participation rate and did patients give informed consent?
4. Unbiased assessment of outcome and determinant?
5. Was the follow-up period appropriate?
6. Did they report a loss to follow-up of less than 20%?
7. Is there any information about the sample size calculation?
8. Were statistical test appropriate and did they adjust for confounders?
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functional recovery and need for assistive devices
9 studies compared functional recovery after the anterior approach to the lateral or pos-
terior approach9,10,34,36,38,45,72,78,82 (Table 4). There is strong evidence for significantly faster 
return to function and daily activity, significantly achieving functional milestones earlier, 
and significantly less time to postoperative recovery, for patients operated through the 
anterior approach in comparison to other approaches (Table 4). Furthermore, a total of 
8 studies compared postoperative need for assistive devices after the anterior approach 
to the lateral or posterior approach9,31,34,37,46,72,78,82 (Table 4). There is strong evidence that 
patients operated through the anterior approach need less assistive devices, like a cane, 
crutches or a walker, for mobilizing postoperatively, in comparison to other approaches 
(Table 4). 
Other outcome parameters
Regarding all other studied outcome parameters, only conflicting evidence was found 
with mainly low quality studies (Table 5). For these parameters, there were no differ-
ences regarding better or worse results for the 2 different surgery tables, or for the use 
of a specific approach when compared to the anterior approach.
learning curve
The effect of a learning curve for the anterior approach was described in 21 studies, of 
which 8 were high quality studies.1,10-12,15,17-21,28,32,46-50,70,79,83,84 Parameters for describing 
this learning curve were surgery time, blood loss, hospital stay, (major) complications, 
component placement, questionnaire scores, and perioperative fluoroscopy time.
All studies investigating surgery time described a clear reduction throughout time, 
after gaining more experience.10,19,20,28,32,46-48,50,70,79,83 This reduction was approximately 
30 minutes. A significant drop in blood loss after gaining more experience is also de-
scribed.10,48,70 Regarding complication rate, the effect of a learning curve was clearly 
demonstrated. However the number of cases when the learning curve was mentioned 
to be ended, varied greatly from 10-200.1,12,15,18,19,21,46,84 Others only studied the first 20-46 
cases and did not observe an ending of the learning curve regarding blood loss, LOS and 
complication rate.20,28 Another study describes that no learning effect regarding surgery 
time is achieved within the first 100 THAs performed through the anterior approach.11
2 studies described improvement of component placement regarding LLD and/or 
positioning of the acetabular component after 100 cases.50,79 Another study describing 
the results of the first 300 cases operated through the anterior approach, demonstrated 
that most outliers regarding median acetabular cup abduction angle occurred during 
the first 100 cases. These first 100 cases had significantly steeper cup positions when 
compared to the second and third 100 cases.49
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Perioperative fluoroscopy time was mentioned twice as parameter for describing the 
learning curve. These studies demonstrated a decrease in time within the first 81 cases,48 
and a significant decrease in time after 100 cases within a total of 300 cases.50
Another 7 studies described reduction in surgery time, blood loss, and/or complica-
tions within the first 30-99 cases, without a clear description of the number of surgeries 
defining the learning curve.17,32,46-48,70,83
A definition of the learning curve is mentioned to be 100 cases, regarding surgery 
time and component placement.50 However, the number of cases in a high volume hip 
arthroplasty center is mentioned to be around 40 cases or 6 months.10 Furthermore, a 
multicenter study among 1,152 patients described surgeons who performed less than 
100 cases through the anterior approach were twofold more likely to have complications 
(20.2 % versus 9.8 %, p = 0.049).1
dIsCussIOn
The purpose of this systematic review was to evaluate the available literature for the 
anterior approach for primary THA in comparison to other approaches. The different 
perioperative and postoperative parameters that were analyzed were surgery time, inci-
sion length, blood loss, complication rate, LOS, postoperative pain and pain medication 
consumption, questionnaire scores, accuracy of component placement, and functional 
recovery. We hypothesized that since muscle attachments are preserved, patients re-
cover faster and experience less pain, in comparison to other approaches. Moreover, we 
hypothesized that there are no differences in other outcome parameters in comparison 
to other approaches. Last, we wanted to investigate if there is a clear description of the 
learning curve for the anterior approach.
This systematic review demonstrates strong evidence that there is no difference in 
component placement between the anterior approach and the different other ap-
proaches. Strong evidence was found for a faster postoperative recovery after primary 
THA through the anterior approach when compared to primary THA through other ap-
proaches. Moreover, strong evidence was found for less need for assistive devices during 
postoperative mobilizing after THA through the anterior approach when compared to 
primary THA through other approaches. All the other parameters studied in this system-
atic review only demonstrated conflicting evidence regarding differences in outcome. 
For these parameters, there were no differences regarding better or worse results for the 
2 different surgery tables, or for the use of a specific approach when compared to the 
anterior approach.
The anterior approach uses a muscle splitting interval and therefore we hypothesized 
that using the anterior approach results in less postoperative pain. However, this sys-
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tematic review demonstrates only conflicting evidence regarding differences in postop-
erative pain and pain medication consumption between the anterior approach and the 
other approaches, although only 1 of the 14 studies demonstrated results against the 
anterior approach. 
Although the anterior approach is sometimes criticized due to its technical difficulty, 
this systematic review demonstrates no higher risk for malposition of component place-
ment when the anterior approach is used. Regarding postoperative complication rate, 
only conflicting evidence was demonstrated. Moreover, no influence of approach was 
seen on surgical site infection in a multivariate regression model in 30,491 THA patients 
operated by the anterior approach.51 Although LFCN neuropraxia is a complication that 
is known for the anterior approach, no differences were observed between patients who 
reported LFCN neuropraxia versus those without symptoms, regarding UCLA, WOMAC, 
SF-12.13 However, although there is conflicting evidence regarding complication rates 
between the anterior approach and the different approaches, the only 3 studies dem-
onstrating results against the anterior approach, were studies describing the first THAs 
performed through the anterior approach.20,28,71 Suggesting that the learning curve for 
this approach should not to be neglected.
The effect of this learning curve for the anterior approach was described in 21 stud-
ies, of which only 8 were high quality studies.1,10-12,15,17-21,28,32,46-50,70,79,83,84 Ending of this 
learning curve varied greatly between these studies and has been mentioned to be 10 
to 200 cases. This high range may be influenced by the experience of surgeons, since a 
multicenter study among 1,152 patients described surgeons who performed less than 
100 cases through the anterior approach were twofold more likely to have complica-
tions.1 Moreover, another study suggests the learning curve might be less in a high 
volume hip center.10 Since these results vary greatly, we conclude the amount of cases 
during the learning curve for the anterior approach is still not clear. However, a learning 
curve for the anterior approach is not unique and is also observed for other approaches 
for THA.28,52 Moreover amounts for learning curves for other approaches to the hip joint 
are still not clear either.
Considering component placement, cup inclination range between 35° to 55° was 
considered accurate.53 Femoral component angulation between 3° varus and 3° valgus 
was considered as accurate aligned.30,54,55 The difference in leg length between the 
contralateral hip and the operated hip was defined as the postoperative LLD and a 
maximum of 10 mm was considered acceptable.53 This systematic review demonstrates 
strong evidence that there was no difference in postoperative component placement 
between the anterior approach and the other different studied approaches.
Some potential limitations of our systematic review need to be discussed. Firstly, 
since the amount of cases for the learning curve is still not clear, not all included studies 
of this systematic review used the same number of cases for the learning curve, and 
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some authors mentioned to be experienced and beyond the learning curve, while other 
authors with the same experience mentioned to be within the learning curve for the 
anterior approach. Although combining all data may give worse results for the anterior 
approach because of the effect of this learning curve, the inclusion of all these studies 
in this systematic review gives a clear overview of all available literature regarding the 
anterior approach.
Second, only 23 “high quality” studies were included in our systematic review. For scor-
ing the internal validity of the selected studies we used 8 questions from existing quality 
assessment tools.23-25 From the total of 64 included studies the majority were qualified 
as “low quality” studies. However, this systematic review is an overview of all available 
literature regarding the anterior approach and it seems there are no more “high quality” 
studies on this topic available. To provide better evidence, more high quality research on 
the differences between the anterior approach and the other approaches needs to be 
done by randomized controlled trials.
In conclusion, this systematic review demonstrates strong evidence that there is no 
difference in approach regarding component placement. Strong evidence was found for 
faster postoperative recovery and less need for assistive devices during postoperative 
mobilizing in favor of the anterior approach when compared to other approaches. All 
the other parameters studied in this systematic review only demonstrated conflicting 
evidence. The learning curve for the anterior approach is still not clear. Although it 
seems surgeon’s experience with this surgical approach influences the outcome. Since 
this systematic review demonstrates that there are few “high quality” studies on this 
subject, more high quality research on the anterior approach needs to be done to pro-
vide better evidence for both differences in outcome between the anterior approach 
and other approaches as well as a clear description of the learning curve.
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AbsTrACT 
This study describes specific complications noticed during the first unselected cases 
operated by anterior approach for THA in our hospital and specific adjustments that 
were applied on the procedure to prevent these complications. We retrospectively 
analyzed the differences between 202 patients who were operated by a standardized 
approach and 248 patients who were operated after adjustments were implemented 
on the procedure. Injury to the lateral femoral cutaneous nerve (LFCN), fractures of the 
greater trochanter and dislocation were specific complications that were noticed with 
the initial technique. 
Prevalence of injury to the LFCN decreased from 7.9 % to 0.8 % (p < 0.001), fractures of 
the greater trochanter decreased from 5.4 % to 0.8 % (p = 0.004) and the incidence of 
dislocation decreased from 4.5 % to 1.6 % (p = 0.074).
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InTrOduCTIOn 
The direct anterior intermuscular approach for THA was first performed by Robert Judet 
in 1947.1 The literature makes numerous positive claims relating to this approach given 
that it uses both an intermuscular and internervous plane.1-9 Preservation of muscle 
attachments to bone improves stability and decreases the risk of dislocation.1,10 Fur-
thermore, a shorter rehabilitation period with less surgical trauma is attributed to the 
muscle splitting interval.7,9,11,12,22 Less pain, shorter hospital stay and less operative time 
are also described for the direct anterior approach.3,5-9,12-14 However this approach is also 
technically demanding and it has its own unique set of specific complications.2,4,11,15,16
In our hospital the anterior supine intermuscular (ASI) approach for THA was intro-
duced in September 2007. We noticed some specific complications with this approach 
after its initial introduction. Firstly, LFCN lesions occurred more often than expected, as 
did greater trochanteric fractures and dislocations. In 2010 we altered the technique in 
order to reduce the specific complications related to the anterior approach.1-5,9,7,10-15,17-19 
We describe the results of the implementation of these alterations with respect to the 
prevalence of general and specific complications.
MATerIAls And MeTHOds 
In this retrospective cohort study we analyzed the differences between two cohorts 
of unselected THA patients operated by ASI approach by one orthopedic surgeon. The 
first cohort of 202 patients was operated between December 2008 and April 2010. The 
surgical approach for this first cohort was standardized as described by Bender et al.6 A 
radiolucent operative table with fluoroscopy was used in all cases. Patients were posi-
tioned supine and both legs were draped free. Femoral exposure was gained through a 
figure-of-four position in which the foot was placed under the contralateral leg. Traction 
devices were not used. 
From May 2010 to October 2010 no ASI procedures were performed. In this period the 
technique was adapted in three ways. 
• The incision was placed more laterally than described originally by Hueter and oth-
ers1,2,6 to prevent injury to the LFCN. In the first cohort the starting point of the inci-
sion was placed approximately two centimeters lateral to the anterior superior iliac 
spine (ASIS) and pointed towards the patella. In the second cohort the skin incision 
was placed five centimeters lateral to the ASIS and pointed towards the head of the 
fibula. (Figure 1 and 2)
• In the first cohort, the release of the lateral capsule was performed with the leg in 
the figure-of-four position. A Hohmann bone retractor was placed at the tip of the 
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figure 1: The altered position of the skin incision. 
The black line represents the position of the initial skin incision as described by Hueter (1,2,6). The double line 
represents the position of the LFCN. The broken line represents the position of the skin incision in cohort 2.
figure 2: The altered position of the skin incision. 
The broken line marks the position of the initial skin incision. The black line marks the position of the altered skin 
incision.
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greater trochanter, which was levered over the tensor fascia lata. The tension that 
was put on the retractor often led to damage to the tensor muscle but also to frac-
tures of the tip of the greater trochanter. In the second cohort, the capsular release 
was performed with the leg in neutral position. This reduced tension on the tensor 
fascia lata. The Hohmann retractor was placed more anterior,  to avoid fractures of 
the vulnerable posterolateral tip of the greater trochanter. Also a blunt bone-hook 
was placed in the femoral osteotomy. With this hook the femur was pulled out of the 
wound instead of pushed out by the retractor.
• A thorough release of the posterolateral and posterior capsule and the external 
obturator tendon will lead to an excellent visualization of the femoral osteotomy 
after which the femoral component is easily placed. The early dislocations of THAs 
in the fi rst cohort were, however, presumed to be due to this extensive dissection.
In the second cohort, this capsular release was performed in a more controlled 
manner. Prior to the release, the femur was elevated out of the wound with a blunt 
bone-hook which was placed in the proximal femur osteotomy. No force was put on 
the Hohmann retractor at the anterolateral point of the greater trochanter (Figure 3). 
The release was limited to the anterolateral capsule. The posterolareral capsule was 
left intact in order to preserve the piriformis, gemelli and the external obturator ten-
figure 3: The altered release of the proximal femur. 
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Schematic view of the pirifomis tendon (1) together with the obturator externus tendon (2) and the proximal 
femur (3). The grey zone (4) represents the capsular attachment that has to be released, the arrow (5) indicates 
the direction of the release. The grey line (6) represents the border of the release of the joint capsule, which should 
not be crossed on the medial side. The blunt bone hook (7) is pulled in the direction of the green arrow, in order 
to elevate the femur out of the wound.
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don attachment.26 The grey line indicated in Figure 3 was never crossed. Only after a 
sufficient release was obtained the leg was placed in a figure-of-four position under 
the other leg with a slight extension in the hip. This was done to obtain better access 
for broaching and femoral component placement. Because of the possible injury to 
the femoral nerve, this extension of the hip never exceeded 30 degrees. 
The second cohort of 248 patients was operated between November 2010 and Decem-
ber 2012.
Both cohorts were compared regarding length of hospital stay, surgery time, the spe-
cific complications mentioned before, and rates of total complications, re-admissions ad 
reoperations. 
Length of hospital stay was measured by number of nights. A standardized hospi-
talization and rehabilitation protocol was used for all cases. Patients were mobilized at 
the day of surgery when possible. Surgery time was measured by number of minutes. 
In case of cementation, the surgery time was corrected by 12 minutes per cemented 
component. 
All femoral components were placed press-fit except for the cases in which insuffi-
cient stability was obtained during surgery. In those cases the femoral component was 
cemented. Age above 70 and insufficient stability were both reasons for cementation of 
the cup, otherwise the cup was placed press-fit. No screws were used to improve unce-
mented cup stability. The used fixation types for both cohorts are mentioned in Table 1. 
There were no significant differences in fixation types between both cohorts (p = 0.166).
Femoral head size depended on the type of cup used and differed between both 
cohorts (p < 0.001). For cohort 1 the most frequent used head size was 28 mm, for cohort 
2 this was 36 mm. Head sizes and prostheses for both cohorts are shown in Table 1. 
Injury of the LFCN was defined as numbness and/or burning sensation on the antero-
lateral thigh. At outpatient visits patients were specifically asked and investigated for 
these symptoms. Fractures of the greater trochanter were analyzed by examination of 
the surgery reports and by retrospective examination of all the available postoperative 
radiographs of the involved hip in comparison to the preoperative radiographs of the 
involved hip by two investigators (YH, SV). Both displaced and non-displaced fractures 
were reported as fractured, even in the absence of symptoms. The rate of dislocations 
was documented via appropriately collected hospital data.
To avoid ‘learning curve issues” the first 50 patients operate on by ASA approach in our 
hospital were excluded. In both cohorts all patients who were operated by ASI approach 
in the mentioned period were included, there were no further exclusion criteria. Follow-
up period was minimally one year. 
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statistical Analysis 
Data analyses were conducted with IBM SPSS Statistics for Mac, version 20. For all 
statistics p-values less than 0.05 were considered significant. If data were not normally 
distributed, data were analyzed using the Mann-Whitney Test, otherwise an indepen-
dent student T-test was done. 
resulTs 
All 450 unselected patients operated by ASI approach were included. There were no 
patients lost to follow up. All patient characteristics are summarized in Table 2. After 
the adjustments were applied on the ASI technique, the prevalence of injury to LFCN 
decreased from 7.9 % to 0.8 % (p < 0.001), fractures of the greater trochanter decreased 
from 5.4 % to 0.8 % (p = 0.004), and the prevalence of dislocation decreased from 4.5 % 
to 1.6 % (p = 0.074) (Table 3). 
Table 1: Femoral head size diameter, fixation types, and prosthesis component types used for the 2 cohorts. 
Cohort 1
N = 202
Cohort 2
N = 248
Total
N = 450
Femoral head size diameter
28 mm 76.5 5.2 37.1
32 mm 1.5 26.2 15.1
36 mm 6.4 68.5 40.7
>36 mm 15.6 0 7.1
Fixation types
Un-cemented 56.9 63.7 60.7
Reversed hybrid 43.1 35.5 38.9
Cemented 0.0 0.8 0.4
Femoral component
Taperloc® (Biomet, Warsaw, In, USA) 100 100 100
 Acetabular component
Apollo® (Zimmer, Warsaw, In, USA) 43.1 19.0 29.8
Magnum® (Biomet, Warsaw, In, USA) 15.4 0 6.9
Mallory-Head® (Biomet, Warsaw, In, USA) 33.7 15.7 23.8
Exceed® (Biomet, Warsaw, In, USA) 7.9 58.5 35.8
Regenerex® (Biomet, Warsaw, In, USA) 0 6.9 3.8
Cohort 1 represents the patients who were operated before the adjustments were applied on the ASI procedure. 
Cohort 2 represents the patients who were operated after the adjustments were applied on the ASI procedure.
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Table 2: Demographics for both cohorts. 
Cohort 1
N = 202
Cohort 2
N = 248
Total
N = 450
p-value
Age (years) 70.9
(SD 9.2)
68.3 
(SD 10.3)
69.5 
(SD 9.9)
0.005
Gender (% female) 69.3 63.7 66.2 0.212
BMI (kg/m²) 26.7 
(SD 3.7)
26.5 
(SD 3.9)
26.6 
(SD 3.8)
0.695
ASA classification (%) I 26.2 27.8 27.1 0.700
II 64.4 63.3 63.8
III 9.4 8.5 8.9
IV - 0.4 0.2
Anesthesia (% spinal) 88.1 92.7 90.7 0.051
Priority (% elective) 100 99.2 99.6 0.201
Diagnosis (% primary) 95.0 94.8 94.9 0.889
Discharge destination (% to home) 84.7 86.7 85.8 0.563
Side (% right) 63.4 46.8 54.2 < 0.001
Cohort 1 represents the patients who were operated before the adjustments were applied on the ASI procedure. 
Cohort 2 represents the patients who were operated after the adjustments were applied on the ASI procedure.
Table 3: Length of hospital stay, surgery time, and rate of complications, readmissions and reoperations 
for the 2 cohorts.
Cohort 1
N = 202
Cohort 2
N = 248
Total
N = 450
p-value
Length of hospital stay (nights) 3.5
(SD 1.4)
2.4
(SD 1.8)
2.9
(SD 1.7)
< 0.001
Surgery time (minutes) 77.8
(SD 22.7)
85.9
(SD 22.2)
82.3
(SD 22.8)
< 0.001
LFCN neuropraxia (%) 7.9 0.8 4.0 < 0.001
Fracture greater trochanter (%) 5.4 0.8 2.9 0.004
Dislocation (%) 4.5 1.6 2.9 0.074
Infection (%) 2.0 1.6 1.8 0.770
Fracture femoral shaft (%) 1.0 1.6 1.3 0.567
DVT (%) 0.5 0.4 0.4 0.884
Pulmonary embolism (%) 0.0 0.0 0.0 1.000
Total complications (%) 19.3 6.9 12.4 < 0.001
Readmission (%) 7.4 4.8 6.0 0.251
Reoperation (%) 6.4 3.2 4.7 0.109
Cohort 1 represents the patients who were operated before the adjustments were applied on the ASI procedure. 
Cohort 2 represents the patients who were operated after the adjustments were applied on the ASI procedure.
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Fractures of the greater trochanter were all chip-fractures and only one patient 
required secondary fixation. In cohort one, a total of eight dislocations occurred for 
femoral head size diameter of 28 mm and one dislocation occurred for a femoral head 
size diameter of 36 mm. In cohort two, two dislocations occurred for femoral head size 
diameter of 28 mm and two dislocations occurred for femoral head size diameter of 
32 mm. All dislocations occurred within 10 weeks of surgery. In cohort one, three hips 
dislocated twice. Two of these required a cup revision. In cohort two, no recurrent 
dislocations occurred. Two dislocations occurred after trauma. Furthermore, one revi-
sion in the second cohort was needed because of femoral subsidence. Mean length of 
hospital stay, mean surgery time, and the rate of other complications, re-admissions and 
reoperations for both cohorts are listed in Table 3. Total rate of complications decreased 
significantly from 19.3 % to 6.9 % (p < 0.001) after the adjustments had been applied on 
the procedure.
dIsCussIOn 
The ASI procedure is known to be technically demanding. This study demonstrates the 
specific complications that can be expected using this approach, which could be poten-
tial pitfalls for other surgeons who perform this approach. We also describe the specific 
adjustments that we made to the procedure to avoid these pitfalls. Furthermore we 
demonstrate the results of the implementation of these adjustments on the prevalence 
of these specific complications. There was a significant decrease in complication rate 
after specific adjustments were applied to the ASI procedure in our hospital. Prevalence 
of injury to LFCN decreased from 7.9 % to 0.8 % (p < 0.001), fractures of the greater tro-
chanter decreased from 5.4 % to 0.8 % (p = 0.004), and the prevalence of dislocation of 
THA decreased from 4.5 % to 1.6 % (p = 0.074). This decrease in the various complications 
could be partly due to the effect of a learning curve. Many publications demonstrated 
that extensive training is necessary for surgeons performing the ASI technique.9,11,15 
There is a decline in complication rate, operating time and blood loss after the surgeon 
has gained more experience.1 In our hospital the ASI approach was introduced in Sep-
tember 2007. Because the known effect of a learning curve and a patient selection for 
the first 50 patients who were operated by ASI approach in our hospital, these first 50 
cases were excluded for this study. 
Although patients were not selected, age differed significantly between both cohorts 
(p = 0.005). Because older age is associated with co-morbidities this could be a reason 
for decrease in the different complication rates. However, there was no significant differ-
ence in ASA classification between both cohorts.
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Mean length of hospital stay decreased significantly between the two cohorts and 
was most likely due to the effect of the learning curve and due to the introduction of the 
rapid recovery protocol in our hospital, which was implemented between January 2009 
and January 2011.22 This introduction of rapid recovery could also explain the difference 
in type of anesthesia between both cohorts, because less general anesthesia is given for 
this protocol. However, this difference in type of anesthesia was not significant between 
both cohorts. 
Mean surgery time for the first cohort was significantly less when compared to the 
mean surgery time for the second cohort. However this mean surgery time for both 
cohorts is less than described in literature.3 We could not well explain this difference 
in surgery time. A possible reason for this could be the awareness of the surgeon of 
the importance of the release of the posterior capsule for the procedure in the second 
cohort. This awareness could result in a longer procedure.
The LFCN and its branches are within the field of dissection between the sartorius 
muscle and the tensor fascia lata muscle and thus at risk of injury.11 This risk is not only 
due to sharp dissection but also to traction lesions. An anatomical study in which the 
LFCN was dissected bilaterally in 17 formalin-preserved cadavers demonstrated that 
numerous anatomical variations of the LFCN should be considered and that the skin 
incision should be placed as lateral and distal to the anterior superior iliac spine as pos-
sible.17 In previous studies the rate of injury of the LFCN was described between 0.5 % 
and 14.8 %.1,4,5,9,12,15,18 Another study reported 67 % sensory deficits in the anterolateral 
thigh area after primary THA in 132 patients and the authors suggest that LFCN injury 
is underreported in general literature.2 However, in this report the incision was placed 
one to two centimeters lateral to the ASIS, which could explain their high rate of LFCN 
injury also. 
Although some studies have described an excellent anatomic vision of both the 
femur and the acetabulum for the ASI approach,7,8,13 femoral exposure and prepara-
tion are very different from more conventional approaches. Therefore it is difficult to 
obtain straight and direct access to the femoral canal,11,18 and a release of the capsule 
has to be performed. Furthermore, release of one or more of the short external rotator 
tendons depending on the requirement for femoral mobility has been described as 
well.1 Insufficient release of the capsule can lead to fractures of the greater trochanter.14 
Equipment related fractures are also described in literature for this approach.5 However 
fractures of the greater trochanter had no consequences for the most of our patients. In 
fact only two patients suffered with clinical consequences, one patient got instructions 
for non-weight bearing mobilization during six weeks, another patient underwent a 
reoperation for re-fixation of the greater trochanter, which did not alter the complaints 
she had before the second procedure. In previous studies the rate of these fractures has 
been described as 6.5 %.3 Fewer incidences of 0.7-1.0 % have also been described.1,13,14 
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However, this could be an underreporting due to the absence of clinical consequences 
in most of the patients. 
Although excessive release of the soft tissue of the proximal femur could result in in-
stability,15 incorrect positioning of the prosthetic components due to minimally releases 
can cause dislocations as well.10,19 Previous studies describe rate of dislocation for the ASI 
approach between 0 % and 2.5 %.1,3,5,7,10,12,13,15,19 These rates of dislocation are significantly 
lower than the dislocation rates generally quoted for other approaches.5,11 
The femoral head size utilized differed significantly between both cohorts. For cohort 
1 the most frequent used head size was 28 mm, for cohort 2 this was 36 mm. This could 
be a reason for the decrease in dislocation rate between both cohorts, because large 
diameter heads are associated with fewer dislocation rates. Moreover, the size of the 
femoral head has been mentioned as a weak influential factor for dislocation.20,21 For 
cohort one, a total of eight dislocations occurred for femoral head size diameter of 28 
mm and one dislocation occurred for a femoral head size diameter of 36 mm. For cohort 
two, a total of two dislocations occurred for femoral head size diameter of 28 mm and 
two dislocations occurred for femoral head size diameter of 32 mm. 
Total rate of complications decreased significantly from 19.3 % to 6.9 % (p < 0.001) 
after the adjustments had been applied on the procedure. This rate of complications 
included injury to the LFCN, dislocations of THA, fractures of the greater trochanter, 
infection, fractures of the femoral shaft, DVT and pulmonary embolism. This rate of 
complications is in accordance to previous studies, which describe a complication rate 
between 5.4 % and 13 %.3,5,13 The re-admission rate decreased from 7.4 % to 4.8 % and 
the reoperation rate decreased from 6.4 % to 3.2 % after the adjustments had been ap-
plied on the procedure, however these decreases were not significant. The re-admission 
rate after THA varies from 4-11 % in literature although some studies only describe the 
re-admission rate within the first three months after surgery.23-25 Our reoperation rate 
is slightly higher than described in literature, however most of these studies again only 
describe the reoperation rate reported within the first three months after surgery.1,5,9
A weakness of this study is that we included both cemented and uncemented pros-
theses. There was no significantly difference between both cohorts for percentage of 
cementation with the same criteria for cementation being used for both cohorts. The 
strength of this study is that it describes all the first 450 unselected cases operated by 
ASI approach by one orthopedic surgeon in our hospital. Follow-up period was a mini-
mum of one year and no patients were lost to follow-up.
In conclusion, the ASI procedure is a technically demanding procedure and has its 
own unique set of complications. We describe the specific adjustments that we made 
to this procedure to avoid these specific complications. After we applied these adjust-
ments the complication rate of injury to the LFCN, dislocation of THA and fracture of the 
greater trochanter all decreased.
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AbsTrACT
Only limited data are available regarding the infiltration of local anaesthetic for total hip 
arthroplasty (THA), and no studies were performed for THA using the anterior approach. 
In this prospective, randomised placebo-controlled study we investigated the effect 
of both standard and reverse infiltration of local anaesthetic in combination with the 
anterior approach for THA. The primary endpoint was the mean numeric rating score for 
pain four hours postoperatively. In addition, we recorded the length of hospital stay, the 
operating time, the destination of the patient at discharge, the use of pain medication, 
the occurrence of side effects and pain scores at various times postoperatively.
Between November 2012 and January 2014, 75 patients were included in the study. They 
were randomised into three groups: standard infiltration of local anaesthetic, reversed 
infiltration of local anaesthetic, and placebo. There was no difference in mean numeric 
rating score for pain four hours postoperatively (p = 0.87). There were significantly more 
side effects at one and eight hours postoperatively in the placebo group (p = 0.02; p = 
0.03), but this did not influence the mobilisation of the patients. There were no differ-
ences in all other outcomes between the groups.
We found no clinically relevant effect when the infiltration of local anaesthetic with 
ropivacaine and epinephrine was used in a multimodal pain protocol for THA using the 
anterior approach.
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InTrOduCTIOn 
Total hip arthroplasty (THA) is associated with considerable postoperative pain,1 most 
of which results from tissue damage at the surgical site.2 Another cause is haematoma 
formation.3 Postoperative pain hinders mobilisation and rehabilitation as well as overall 
recovery.4 The challenge of analgesic regimens for THA is to obtain adequate pain relief 
and maximum muscle control to enable the patient to mobilise and rehabilitate early, 
without causing side effects.5
Local anaesthetic may be infiltrated into the tissues around the surgical field to 
achieve control of pain while avoiding physiological disturbance,2 and this is nowadays 
widely used as part of a multimodal pain management strategy, owing to its simplicity 
and apparent safety. Local infiltration has been reported to be effective in total knee 
arthroplasty (TKA);4,6,7 however, for THA only limited and inconclusive data are available 
from placebo-controlled and randomised trials.1,5,8-12 None of these studies reported on 
the use of local infiltration when the anterior approach is used for THA. This approach is 
used for THA in our hospital. Lower postoperative pain scores and lower consumption of 
analgesics has been described when this approach is used.13-18 We hypothesised that the 
infiltration of local anaesthetic as part of a multimodal pain protocol in THA undertaken 
using the anterior approach would reduce pain postoperatively. We also introduced 
a reverse infiltration method, in which local anaesthetic is administered before the 
incisions are made. We hypothesised that this would reduce postoperative pain even 
further, as the anaesthetic can be injected more accurately in tissues that have not yet 
been damaged. We therefore investigated the effect of both standard and pre-incision 
local anaesthetic infiltration in combination with the anterior approach for primary THA.
PATIenTs And MeTHOds
In this prospective, randomised placebo-controlled trial we included patients with os-
teoarthritis (OA) of the hip, for whom primary THA had been recommended with surgery 
being performed through the anterior approach. The operations were performed by a 
single surgeon (SV). The patients were all American Society of Anesthesiologists (ASA)19 
grades I and II. Exclusion criteria included mental illness, a medical contraindication for 
spinal anaesthesia, neurological conditions that might influence the perception of pain, 
cardiovascular impairment in the present or past, allergy to any element of the medica-
tion in the protocol, alcohol or drug abuse, rheumatoid arthritis (RA) and a body mass 
index (BMI) > 40 kg/m2. The study had ethical approval (NL39970.098.12, METC 12-029) 
and was registered in EudraCT (2012-000989-37). All patients were admitted on the day 
of surgery.
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A nurse randomised patients in the operating theatre, just prior to surgery. Opaque 
sealed envelopes were used to randomise them into three different groups. Group 1 
patients received local anaesthetic by standard infiltration; group 2 patients received 
local anaesthetic by reversed infiltration; and group 3 patients received placebo by 
infiltration of saline at 0.9 %.
Local anaesthetic was infiltrated in a clockwise peri-acetabular fashion after reaming 
the acetabulum, and then into the capsule and the gluteus minimus and medius muscles. 
The vastus lateralis muscle and the tensor fascia lata were infiltrated after introducing 
the femoral component, and infiltration of the subcutaneous tissue was undertaken just 
before closure of the wound. Reverse infiltration started with infiltration of the subcu-
taneous tissue followed by incision of the skin and subcutaneous tissue; infiltration of 
the capsule, the gluteus minimus and medius muscle and the vastus lateralis and tensor 
fascia lata muscle was followed by incision of the joint capsule; and a clockwise peri-
acetabular infiltration was undertaken just before reaming the acetabulum. A total of 
100 mL of local anaesthetic was used for peri-acetabular infiltration and for infiltration of 
the capsule, the gluteus minimus and medius muscle and the lateral vastus muscle; and 
20 mL were used for infiltration of the subcutaneous tissue. The infiltration consisted of 
ropivacaine 2 mg/ml and adrenalin 1 mg/ml in a ratio of 99:1.
No drains were used postoperatively. All patients received spinal anaesthesia with a 
low dose of bupivacaine (6 mg to 8 mg). Propofol is given by Target Controlled Infusion 
(TCI), which is often used in anaesthesia to control the concentration of selected drugs 
in the plasma or at the site of its effect. In our protocol patients received propofol 1-2 
mcg/ml set as target concentration administered through a TCI diprifusorpump20,21 us-
ing the Marsh model.22
A standardised protocol of oral postoperative medication consisted of 1 g paracetamol 
four times a day, celecoxib 200 mg, gabapentin 300 mg and tramadol 100 mg (one dose 
of each, only for the first night after operation). Rescue medication consisted of the opi-
oid piritramide 10 mg (maximum six times a day) and extra celecoxib 200 mg (maximum 
once a day). Postoperative physiotherapy was undertaken twice a day, starting four to 
six hours after surgery and focusing on regaining function, movement and gait.
All patients received the same regimen. The discharge criteria were functional: the 
ability of the patient to walk 30 metres with crutches, to climb stairs and to dress and go 
to the bathroom independently. In addition, adequate pain relieve had to be achieved 
before discharge. The numeric rating score (NRS; zero to ten, best to worst.) for pain 
had to be < 3 at rest and < 5 during mobilisation. All patients were reviewed six weeks 
postoperatively.
The primary endpoint of this study was the mean NRS for pain, four hours after 
surgery. We expected the influence of local anaesthetic infiltration to be greatest at 
this time.5-7 The clinically relevant difference in NRS was defined as a mean reduction 
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of 3 points,23 which represents a decrease in the severity of pain that corresponds to a 
patients’ perception of adequate pain control. Secondary endpoints were the length of 
stay in hospital (LOS; nights); operating time (minutes); the destination of the patient at 
discharge; the extent of postoperative use of (rescue) pain medication and the amount 
and duration of side effects of pain medication and anaesthesia. The postoperative 
NRS for pain was also measured at many other times: at one hour and eight hours after 
surgery; before and after mobilisation; and at the time of the least and most severe 
pain reported on that day; at days 1 and 2 after surgery in the morning and afternoon; 
before and after mobilisation twice a day; and the time of the least and most severe pain 
experienced that day.
Nurses and physiotherapists, who were blinded to the group in which the patient was 
randomised, scored the NRS for pain, the amount pain medication which was used and 
the extent and duration of side effects including urinary retention, cardiac arrhythmia, 
dizziness, hypotension, convulsions, headache and nausea and vomiting at the different 
times. The investigator (YH) who analysed the data was blinded, as were the patients. 
The surgeon (SV) also was blinded for both standard infiltration groups. Data were 
analysed after all included patients were discharged. At that moment the researcher 
was unblinded.
statistical analysis 
No relevant literature describing the effect of reversed local anaesthetic infiltration with 
primary THA was found, nor on the effect of local infiltration used during THA using the 
anterior approach. Therefore, the sample size calculation was based on analysis of vari-
ance (ANOVA) for the three groups and a clinically relevant difference in NRS of 3.23 Based 
on a resulting effect size of 0.7, a sample size of 25 per group was needed. This resulted 
in 75 patients in total, divided into the three groups.
Data were not normally distributed. Therefore, the Kruskall–Wallis test was used to 
analyse differences between the three groups, four hours after surgery (ordinal data). If 
needed, a post hoc Mann–Whitney U test was performed with a Bonferroni adjustment. 
Nominal data were analysed with a chi-squared test. Results within the groups were ana-
lysed with a Friedman test and a post hoc Wilcoxon’s signed ranks test, if needed, and p < 
0.05 was considered significant. Data are presented as means and ranges. Data analysis 
was conducted with IBM-SPSS Statistics version 20 (IBM-SPSS, Armonk, New York).
resulTs
Between 1 November 2012 and 9 January 2014 a total of 75 patients were included in 
the study, randomised into three groups of 25. One patient in group 2 was excluded 
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figure 1: Flowchart of patients.
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because general anaesthesia was given during surgery. No patients were lost to follow-
up (Figure 1).
The mean age of the patients was 67.1 years (42.7 to 84.6) and the mean BMI was 27.1 
kg/m2 (20.1 to 38.9). Most patients were women and lived with a partner. The demo-
graphics of the patients are shown in Table 1. One patient had a previous arthroscopy of 
the ipsilateral hip and 16 patients had undergone contralateral THA.
An uncemented THA (a Universal acetabular component and a Taperloc femoral 
component; Biomet, Warsaw, Indiana) was used in 74 patients; one patient received a 
cemented THA (Exceed Muller acetabular component and a Taperloc femoral prosthesis, 
Biomet) because of severe osteoporosis. The mean LOS was 1.8 nights (one to seven) 
and mean operating time was 79.2 minutes (49 to 116). Most patients were discharged to 
their own home (Table 2).
There was no significant difference in the mean NRS for pain four hours after surgery 
between the groups (Table 2). Furthermore, the LOS, operating time, the destination of 
the patient at discharge (Table 2), use of (rescue) pain medication (Table 3) and mean 
NRS for pain at the other times (Table 4) did not differ significantly between the groups.
There were significantly more side effects at one and eight hours postoperatively in 
group 3 when compared with group 2 (Table 5). Side effects that occurred after one 
Table 1: Patient demographics. Data are presented as mean and range, unless otherwise described.
Group 1
n = 25
Group 2
n = 24
Group 3
n = 25
Total
n = 74
Age (yrs) 64.3 (42.7 – 83.9) 69.0 (48.7 – 84.6) 68.0 (55.0 – 83.7) 67.1
BMI (kg/m2) 27.0 (22.4 – 37.6) 27.6 (21.0 – 38.9) 26.7 (20.1 – 38.1) 27.1
Gender (n) male 10 13 13 36
ASA classification (n) I 12 6 9 27
Living situation (n) alone 6 6 4 16
Table 2: Mean numeric rating score (NRS) at four hours postoperatively, length of stay (LOS), surgery dura-
tion and destination of discharge for the three different groups. Data are presented as mean and range, 
unless otherwise described. Data analyses were performed with a Kruskall-Wallis test (NRS decrease, LOS, 
surgery time), and a chi-squared test (destination of discharge). 
Group 1
n = 25
Group 2
n = 24
Group 3
n = 25
Total
n = 74
p-value
NRS at 4 hrs postoperatively 3.1 (0.0 – 9.0) 2.9 (0.0 – 7.0) 2.9 (0.0 – 6.0) 3.0 0.87
LOS (nights) 1.8 (1 - 7) 1.8 (1 - 4) 1.8 (1 - 3) 1.8 1.00
Surgery duration (mins) 76.3 (49 – 113) 81.4 (57 – 116) 80.1 (50 – 111) 79.2 0.53
Destination discharge (n to home) 25 22 25 72 0.66
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Table 3: Number of patients using (rescue) pain medication for the three different groups. Data analyses 
were performed with a chi-squared test.
Pain medication Group 1
n = 25
Group 2
n = 24
Group 3
n = 25
p-value
Day 0 1 hr postoperative 4 5 4 0.88
4 hrs postoperative 23 22 23 0.99
8 hrs postoperative 23 21 22 0.53
Day 1 Morning 25 22 23 0.34
Afternoon 17 18 17 0.30
Day 2 Morning 11 14 15 0.34
Afternoon 2 3 7 0.12
Rescue medication
Day 0 1 hr postoperative 6 2 3 0.27
4 hrs postoperative 3 1 2 0.56
8 hrs postoperative 4 3 3 0.69
Day 1 Morning 1 0 0 0.40
Afternoon 0 1 1 0.29
Day 2 Morning 0 0 0 1.00
Afternoon 1 0 1 0.11
Table 4: Mean numeric rating scores (NRS) at multiple moments for the three different groups. Data are 
presented as mean and range. Data analyses were performed with a Kruskall-Wallis test.
NRS Group 1
n = 25
Group 2
n = 24
Group 3
n = 25
Total p-value
Day 0 1 hr postoperative 1.3 (0.0 – 7.0) 1.4 (0.0 – 8.0) 1.9 (0.0 - 6.0) 1.5 0.20
Before mobilisation 2.7 (0.0 – 6.0) 2.8 (0.0 – 6.0) 2.4 (0.0 – 6.0) 2.6 4.88
After mobilisation 3.2 (0.0 – 10.0) 2.7 (0.0 – 6.0) 2.9 (0.0 – 6.0) 2.9 0.88
8 hrs postoperative 2.9 (0.0 – 8.0) 2.3 (0.0 – 6.0) 2.1 (0.0 – 7.0) 2.4 0.56
Less pain that day 0.8 (0.0 – 3.0) 0.8 (0.0 – 3.0) 0.9 (0.0 – 3.0) 0.8 0.77
Most pain that day 4.1 (0.0 – 10.0) 3.7 (0.0 – 6.0) 3.7 (0.0 – 8.0) 3.8 0.80
Day 1 Morning 2.4 (0.0 – 5.0) 1.4 (0.0 – 5.0) 1.1 (0.0 – 3.0) 1.6 0.39
Before mobilisation morning 2.5 (0.0 – 7.0) 1.6 (0.0 – 4.0) 1.0 (0.0 – 3.0) 1.7 0.09
After mobilisation morning 3.0 (0.0 – 9.0) 2.2 (0.0 – 5.0) 1.5 (0.0 – 4.0) 2.3 0.09
Afternoon 1.9 (0.0 – 6.0) 1.5 (0.0 – 5.0) 1.3 (0.0 – 3.0) 1.6 0.87
Before mobilisation 
afternoon
1.6 (0.0 – 4.0) 1.3 (0.0 – 4.0) 1.1 (0.0 – 3.0) 1.3 0.66
After mobilisation afternoon 1.7 (0.0 – 4.0) 2.0 (0.0 – 5.0) 1.5 (0.0 – 6.0) 1.7 0.30
Less pain that day 1.2 (0.0 – 3.0) 0.9 (0.0 – 3.0) 0.7 (0.0 – 5.0) 0.9 0.34
Most pain that day 4.0 (2.0 – 8.0) 3.5 (0.0 – 10.0) 3.1 (1.0 – 7.0) 3.5 0.33
Day 2 Morning 2.6 (1.0 – 6.0) 1.9 (0.0 – 4.0) 1.6 (0.0 – 7.0) 2.0 0.17
Before mobilisation morning 2.7 (0.0 – 6.0) 1.3 (0.0 – 3.0) 0.9 (0.0 – 3.0) 1.5 0.42
After mobilisation morning 2.2 (0.0 – 4.5) 1.9 (0.0 – 3.5) 1.5 (0.0 – 4.0) 1.8 0.35
Afternoon 1.3 (0.0 – 2.0) 2.5 (2.0 – 3.0) 1.6 (0.0 – 3.0) 1.8 0.15
Before mobilisation 
afternoon
1.8 (1.0 – 2.0) 1.5 (0.0 – 3.0) 0.9 (0.0 – 2.0) 1.3 0.38
After mobilisation afternoon 2.5 (2.0 – 4.0) 2.3 (0.0 – 3.0) 1.4 (0.0 – 3.0) 1.9 0.24
Less pain that day 1.3 (0.0 – 2.0) 1.5 (0.0 – 3.0) 0.6 (0.0 – 2.0) 1.1 0.25
Most pain that day 3.7 (2.0 – 6.0) 3.5 (3.0 – 4.0) 3.4 (1.0 – 7.0) 3.5 0.62
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Table 5: Number of patients in whom side effects occurred for the three different groups. Data analyses 
were performed with a chi-squared test.
Nausea Group 1
n = 25
Group 2
n = 24
Group 3
n = 25
p-value
Day 0 1 hr postoperative 0 0 2 0.13
4 hrs postoperative 1 1 0 0.59
8 hrs postoperative 1 1 0 0.55
Day 1 Morning 1 2 3 0.60
Afternoon 1 0 1 0.40
Day 2 Morning 1 2 0 0.36
Afternoon 1 0 0 0.05
Vomiting
Day 0 1 hr postoperative 0 0 2 0.13
4 hrs postoperative 0 0 0 1.00
8 hrs postoperative 1 0 1 0.56
Day 1 Morning 1 0 2 0.40
Afternoon 0 0 1 0.32
Day 2 Morning 0 1 0 0.27
Afternoon 0 0 0 1.00
Other side effects
Day 0 1 hr postoperative 3 1 7 0.05
4 hrs postoperative 3 4 3 0.86
8 hrs postoperative 1 0 6 0.02
Day 1 Morning 3 3 6 0.52
Afternoon 2 4 3 0.67
Day 2 Morning 2 2 6 0.16
Afternoon 0 0 3 0.04
All side effects
Day 0 1 hr postoperative 3 1 11 0.02*
4 hrs postoperative 4 5 3 0.86
8 hrs postoperative 3 1 7 0.03†
Day 1 Morning 5 5 11 0.82
Afternoon 3 4 5 0.87
Day 2 Morning 3 5 6 0.29
Afternoon 1 0 3 0.17
* p-values for differences within the groups: p = 0.32 (group 1-2); p = 0.01 (group 2-3); p = 0.09 (group 1-3)
† p-values for differences within the groups: p = 0.64 (group 1-2); p = 0.02 (group 2-3); p = 0.07 (group 1-3)
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hour were dizziness, hypotension and retention of urine. Side effects that occurred after 
eight hours were dizziness, headache and retention of urine, and this included two of 
the patients who developed retention one hour postoperatively. However, these side 
effects did not influence mobilisation. No differences between the three groups were 
seen at the other times.
Adequate pain relief was achieved in all patients before discharge. Two had a LOS of 
> three nights. One patient had a LOS of seven nights due to a fracture of the femur on 
the same side after a fall; this was not, however, a consequence of cardiac arrhythmia, 
dizziness, convulsions or hypotension. The prolonged LOS for the other patient (four 
nights) was due to waiting for sufficient aftercare.
dIsCussIOn
This was a randomised, placebo-controlled trial in which we investigated the effect of 
both standard and reverse local anaesthetic infiltration in combination with the ante-
rior approach for primary THA. No differences in NRS for pain four hours after surgery 
were detected between the three groups. Furthermore, there was no difference in LOS, 
operating time, destination of the patient at discharge, use of (rescue) pain medication, 
and mean NRS for pain at the other times between the three groups. Thus, it seems that 
a multimodal pain medication regimen provides adequate postoperative pain relief for 
patients undergoing THA using the anterior approach, and the addition of local anaes-
thetic to this protocol has no clinically relevant effect.
There were statistically significantly more side effects at one and eight hours postop-
eratively in the placebo group than in the reverse local infiltration group, although these 
side effects did not have an influence on postoperative mobilisation and numerically 
were still infrequent. The side effects that we studied were urinary retention, cardiac 
arrhythmia, dizziness, hypotension, convulsions, headache and nausea and vomiting. It 
seems unlikely that these were influenced by the lack of local anaesthetic in the control 
group.
In our study, all patients received spinal anaesthesia with a low dose of bupivacaine 
and at this dose no prolonged analgesic side effects are expected. The postoperative 
pain could therefore be measured under comparable conditions. The NRS after surgery 
ranged from 0 to 10 at various times, but no differences were found in mean pain scores 
or decrease in scores between the three groups. All groups included patients with high 
pain scores. Therefore, it seems that the high pain scores of the non-responders are due 
to factors other than those which were investigated, such as psychosocial, behavioural 
and psychophysiological factors.24,25 Further research on patients with persistent pain 
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despite pain management is therefore required. Two patients had a LOS of > three 
nights, but these were not due to inadequate pain relief or its side effects.
Only limited and inconclusive data are available regarding the effect of the infiltration 
of local anaesthetic for THA. Kerr and Kohan2 reported satisfactory results, but without 
the use of a control group. Two studies recorded a good response to local infiltration in 
comparison with a placebo. However, no multimodal pain protocol was used, and in one 
study5 there was a predominance of men in the local infiltration group. The other study 
combined the results of patients undergoing TKA and THA.8 Compared with epidural 
infusion9 or patient-controlled analgesia (PCA),1,10 positive effects of local infiltration 
were also described. However, the study comparing local infiltration with epidural 
infusion was not blinded and did not use a multimodal pain protocol. Moreover, one 
study comparing local infiltration to PCA was underpowered.1 No effect of local infiltra-
tion compared with placebo was seen in two other studies.11,12 None of these studies, 
however, reported on the use of local infiltration with the anterior approach to the hip. 
In the literature, there seems to be a consensus on the use of local infiltration dur-
ing TKA.4,6,7 Although postoperative pain scores are higher after TKA than after THA,26 
one would expect some effect of local infiltration in THA. The minimal or absent effect 
in other studies could be the result of the difficulty of administering local infiltration 
at the sites where damage to the tissues is caused both during and at the end of the 
procedure. It seems easier to detect damaged or affected tissues after TKA. We therefore 
hypothesised that the reversed infiltration would be more effective, but this method of 
administration did not seem to influence the effect. 
Not all postoperative pain arises as a result of tissue damage at the surgical site. A local 
haematoma causes pain.3 The anteromedial part of the hip joint is innervated by the 
obturator nerve, the anterior hip capsule by the femoral nerve, the posteromedial part 
of the capsule by the sciatic nerve and the posterolateral part by the superior gluteal 
nerve.27 In the event of haematoma formation, all these areas might be affected. Appar-
ently, it is not possible with the current technique of local infiltration to give an effective 
blockade to all these nerves in all patients.
We hypothesised that local infiltration combined with a multimodal pain protocol 
in THA using the anterior approach would reduce pain scores postoperatively. The 
advantages of the anterior approach regarding early function rehabilitation, lower 
postoperative pain scores and less pain medication consumption have been described 
elsewhere.13-18,28 This could account for the absence of a clinically relevant effect of local 
infiltration when using this surgical approach.
In conclusion, this prospective, randomised placebo-controlled trial showed no 
clinically relevant effect when local anaesthetic infiltration is used with ropivacaine and 
adrenaline in a multimodal pain protocol for THA using the anterior approach.
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AbsTrACT
Total hip arthroplasty (THA) is associated with considerable postoperative pain as a 
result of tissue damage at the surgical site. Single-shot local infiltration analgesia (LIA) is 
based on a systematic infiltration of local analgesics into the tissues around the surgical 
field to achieve satisfactory pain control with little physiological disturbance. However, 
for THA no clinical relevant effect of LIA is detected. The reason for lack of effect of LIA 
for THA is not yet clear. The purpose of this study was to elucidate pharmacokinetic 
parameters of ropivacaine administered by LIA in THA patients.
LIA for THA in our hospital consists of ropivacaine and epinephrine given in three 
syringes. For determining ropivacaine serum concentrations, blood samples were col-
lected at multiple moments from just before infiltration, until 48 hours after infiltration 
of the first LIA mixture.
Pharmacokinetic analysis of serum concentrations of ropivacaine was performed.
A total of 12 patients was included in this prospective-cohort pilot-study. Cmax was 0.52 
mg/l (SD 0.19) and Tmax was 6.0 h (SD 2.0). The mean Weibull rate constant was 0.039 h-1 
(SD 0.011) and the mean shape factor was 1.03 (SD 0.18). 
This pilot-study demonstrates a pharmacokinetic model for absorption and diffusion of 
ropivacaine after LIA for THA. These parameters do not differ from those for total knee 
arthroplasty. It seems not likely that a higher dose of ropivacaine can optimise the effect 
of LIA after THA. Serum levels of ropivacaine in our study never exceeded toxicity levels.
Clinical pharmacokinetics of ropivacaine using LIA in THA 117
8
InTrOduCTIOn 
Total hip arthroplasty (THA) is associated with considerable postoperative pain as a 
result of tissue damage at the surgical site.1,2 This postoperative pain hinders mobilisa-
tion and rehabilitation with consequences on mobility, duration and overall recovery.3 
The challenge of analgesic regimes for THA is to obtain adequate pain relief and maxi-
mum muscle control to enable the patient to mobilise and rehabilitate early without 
troublesome side effects.4 Single-shot local infiltration analgesia (LIA) is based on a 
systematic infiltration of local analgesics into the tissues around the surgical field to 
achieve satisfactory pain control with little physiological disturbance2 and is nowadays 
widely applied as part of a multimodal pain management strategy due to its simplicity 
and apparent safety.5,6 The analgesic ropivacaine is frequently used for this technique.2 
LIA has been reported to be effective in total knee arthroplasty (TKA).7-9 However, for 
THA mostly limited and inconclusive data are available from placebo-controlled and 
randomised trials.1,4,10 Most studies describe protocols based on best practices with only 
limited publication on the doses used. Our own recent randomised controlled trial on 
LIA for THA demonstrated no clinical relevant effect when LIA with ropivacaine and epi-
nephrine is applied in a multimodal pain protocol for THA with the anterior approach.11
The reason for lack of effect of LIA for THA is not yet clear; differences in ropivacaine 
pharmacokinetics of the locally applied analgesics between TKA and THA might be 
responsible for this. 
Although several studies describe pharmacokinetics of ropivacaine after epidural 
and intravenous administration,12-15 and even after continuous perfusion in the surgical 
wound after major joint replacement surgery,10  pharmacokinetic parameters of ropiva-
caine for the application route of one-shot LIA for THA have not been investigated yet. 
The purpose of this study was to elucidate pharmacokinetic parameters of ropivacaine 
administered by one-shot LIA in THA patients, by determining the concentration-time 
correlation of ropivacaine in serum. With clarified pharmacokinetic parameters of 
ropivacaine after THA, we could investigate possible causes for lack of effect of LIA after 
THA. Furthermore, recommendations about the dose of ropivacaine in LIA for THA can 
be done, to possible improve the analgesic effect of LIA. Moreover, a statement about 
toxicity of the determined ropivacaine serum levels after LIA for THA can be made.
MeTHOds
In this prospective-cohort pilot-study we included patients with osteoarthritis of the 
hip who were diagnosed for primary THA, who were aged 18 years and older, and were 
willing to participate. Exclusion criteria are listed in Table 1.
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The local Medical Ethics Committee decided that the study did not fall under the 
scope of the Medical Research Involving Human Subjects Act because of the minimally 
invasive burden for patients. However, written informed consent was obtained from all 
patients. 
One-shot LIA for THA in our hospital consists of ropivacaine (2 mg/ml) and epineph-
rine (1 mg/ml) in a ratio of 99:1, given in three syringes of 50 ml each infiltrated into 
tissues around the surgical field. One syringe is infiltrated in a clockwise infiltration 
periacetabular, after reaming the acetabulum. The second syringe is infiltrated into the 
gluteus minimus muscle, the gluteus medius muscle, and the vastus lateralis muscle, 
after placing the femoral component. The third syringe is infiltrated in the subcuteal 
tissue, just before closure of the wound. 
Standard blood samples were taken at one till three days before surgery and 24 hours 
after surgery to assess bilirubin and serum albumin for determining patients’ liver func-
tion. 
For determining ropivacaine serum concentrations, extra peripheral venous blood 
samples were collected through an internally mounted venous cannula just before infil-
tration and at 30 minutes, at 1, 2, 4, 8, 12, 24, 36, and 48 hours after infiltration of the first 
LIA mixture. In case the patient was discharged from the hospital within 48 hours after 
infiltration of the first LIA mixture, serum concentrations were determined just before 
discharge as well. 
Blood samples were stored at 2 to 8 ºC for a maximum period of 24 hours. The samples 
were centrifuged and serum was stored in the freezer at -18 ºC until determination. Ropi-
vacaine in these serum samples was analysed according to a standard validated analyti-
cal procedure in the laboratory for pharmacy of Reinier de Graaf Hospital. Total serum 
ropivacaine concentration was measured with a reversed-phase high-performance 
liquid chromatography method with Diode Array Detection. 
Pharmacokinetic (PK) analysis of the serum concentrations of ropivacaine was per-
formed by using the computer program MwPharm (version 3.83; MediWare, Zuidhorn, 
The Netherlands).16,17 Since a full pharmacokinetic analysis was not possible due to the 
lack of data after intravenous administration, we choose for the following procedure. 
The pharmacokinetic model was taken from Simon et al.,12 who described a 3-compart-
ment model after intravenous administration of deuterium-labelled ropivacaine in 
Table 1: Exclusion criteria.
• Unwilling to participate
• Known allergy for amide-type local anaesthetics
• Morbid obesity (BMI ≥ 40 kg/m2)
• Liver failure (total bilirubin > 34 µmol/l, serum albumin < 35 g/l)
• Using CYP1A2 inhibitors or CYP3A4 inhibitors
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patients participating in their study on the effect of age on the systemic absorption and 
systemic disposition of ropivacaine after epidural administration. For our study, we used 
the PK parameters of patients over 60 years (group 3 of Simon et al.12). For clearance (CL), 
fast distribution clearance (CLd(r), denoted CL12 in MwPharm), slow distribution clear-
ance (CLd(s), denoted CL13 in MwPharm), and volume of the central compartment (Vc, 
denoted V1 in MwPharm) values were taken from table 2 of Simon et al.,12 after conver-
sion to the appropriate units. The volumes of the shallow peripheral compartment (V2) 
and deep peripheral compartment (V3) were derived from the values for the volume of 
distribution at steady state and elimination half-life. The resulting parameter values, nor-
malised to body weight, were: CL 18 l/h/70 kg, CL12 58 l/h/70 kg, CL13 24 l/h/70 kg, V1 0.10 
l/kg, V2 0.18 l/kg, V3 0.41 l/kg. The standard deviation of the inter-individual variability 
was not reported for each parameter in the paper of Simon et al.12 Therefore we assumed 
that the coefficient of variation for the clearance parameters (CL, CL12, CL13) was 40%, 
i.e., close to that of CL in table 2 of Simon et al, and for the volume parameters (V1, V2, 
V3) was 30%, i.e., close to that of V1. The population parameters of the intravenous model 
were fixed during the analysis, but individual values were estimated for each patient. 
Several models describing the absorption kinetics from the site of administration to 
the central compartment were tested: first-order with lag-time, zero-order with lag-
time, Gamma function, Weibull function and Inverse Gaussian function. Bioavailability 
was estimated during the analysis, or fixed to 1. The model parameters of the absorption 
function were estimated using the Iterative Two-Stage Bayesian analysis implemented 
in MwPharm.
The residual standard deviation was estimated during the population analysis, using 
additional, proportional and combined additional and proportional error models. The 
Akaike Information Criterion (AIC) of each model was calculated to select the best fitting 
model. 
Table 2: Demographics of the included patients and patients’ liver function. All data are presented as mean, 
standard deviation and range.
Mean Range
Age years 68 (SD 11) 47 – 85
BMI kg/m2 26.9 (SD 2.1) 22.1 – 30.3
eGFR* ml/min 94 (SD 34) 50-154
Total Bilirubin µmol/l 6.8 (SD 1.7) 5 -10
Albumin g/l 37 (SD 4) 30 - 42
ALAT U/l 30 (SD 22) 15 -88
* eGFR (ml/min/1.73m2) calculated with the Cockcroft and Gault formula
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Mean total serum maximum ropivacaine concentration (Cmax) and mean time for 
reaching maximum ropivacaine concentration (Tmax) were determined from the ob-
served serum concentration data.
We could not perform a clear sample size calculation, since no relevant literature on 
concentration-time correlation of ropivacaine in serum could be found. Therefore we 
decided to perform a pilot study on 12 patients.
resulTs
A total of 12 patients was included in this study, consisting of seven men and fi ve women. 
Mean age was 68.2 years (SD 10.9) and mean BMI was 26.9 kg/m2 (SD 2.1). Demographics 
of the included patients are listed in Table 2.
Cmax was 0.52 mg/l (SD 0.19; range 0.27 - 0.87) and Tmax was 6.0 h (SD 2.0; range 2.8 - 9.3). 
In most patients a second peak in the curve after administration of the fi rst LIA injection 
was detected as well (Figure 1).
Comparing the absorption models tested, the Weibull model was found to fi t best to 
the data, resulting in the lowest AIC value (-73), compared to the fi rst-order with lag-time 
(-11), zero-order with lag-time (+30), Gamma function (-19) and Inverse Gaussian func-
tion (-6). The model with bioavailability fi xed to 1 and a proportional error resulted in the 
lowest AIC value, with a proportional error of 29%.
figure 1: Graphical presentation of the Weibull function of patient 2.
The upper line represents the individual model predicted ropivacaine serum concentration, the lower line repre-
sents the population predicted ropivacaine serum concentration, and the dots represent observed ropivacaine 
serum concentrations.
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The results with the Weibull model for all patients are listed in Table 3. The mean 
Weibull rate constant was 0.039 h-1 (SD 0.011) and the mean shape factor was 1.03 (SD 
0.18). A graphical presentation of the serum concentration with the Weibull absorption 
function for a typical patient is shown in Figure 1. 
dIsCussIOn
The purpose of this study was to elucidate pharmacokinetic parameters of wound-infil-
trated ropivacaine in THA administered by one-shot LIA. Regarding LIA for THA, mostly 
limited and inconclusive data are available from placebo-controlled and randomised 
trials.1,4,10 With clarified pharmacokinetic parameters of ropivacaine after THA, we could 
investigate possible causes for lack of effect of LIA after THA. 
Regarding pharmacokinetic parameters of ropivacaine after continuous perfusion 
in the surgical wound after major joint replacement surgery, mean Cmax is described to 
be 0.71 µg/ml (range 0.30 – 1.28) and Tmax was reached 24 h after initiation of the infu-
sion.10 Our Cmax was 0.52 mg/l (range 0.27 - 0.87) and Tmax was 6.0 h (range 2.8 - 9.3). The 
difference in Tmax can be explained by the continuous perfusion in the surgical wound 
after surgery in the study of Bianconi et al.10
Table 3: Results with the Weibull model including rate constant (kd), and shape factor (n) together with 
standard errors (SE) for all 12 patients. Furthermore mean kd and n for the population are presented, to-
gether with the standard deviation.
Patient kd
unit/h
SE n SE
1 0.0369 0.0085 0.82 0.08
2 0.0499 0.0119 0.75 0.07
3 0.0316  0.0060 1.02 0.07
4 0.0406  0.0053 1.16 0.07
5 0.0416  0.0085 1.04 0.09
6 0.0298  0.0065 1.04 0.08
7 0.0387  0.0086 1.10 0.10
8 0.0482  0.0045 1.17 0.08
9 0.0412  0.0086 1.19 0.10
10 0.0540  0.0045 1.17 0.08
11 0.0347  0.0085 0.89 0.08
12 0.0337  0.0076 1.16 0.09
Population 0.0394 
(SD 0.0109)
1.03
(SD 0.18)
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Our study demonstrates no differences between pharmacokinetic parameters 
of ropivacaine after LIA in THA and after one-shot LIA in TKA with similar doses of 
ropivacaine (referred to unpublished data from our departments). Moreover, since these 
pharmacokinetic parameters do not differ from those of one-shot TKA and since doses 
of ropivacaine are the same for THA and TKA, lack of effect of LIA seems not to be due 
to the dose of ropivacaine used in THA either. Therefore, we conclude that other causes 
than pharmacokinetic parameters of ropivacaine are responsible for lack of effect of LIA 
after THA and it seems unlikely that a higher dose of ropivacaine can optimise the effect 
of LIA after THA.
Ropivacaine blocks nociceptors around the joint. Apparently it is not possible with 
the current one-shot LIA technique to give an effective blockage of all these nociceptors 
around the hip joint.
Systemic toxicity is a major concern of high dose local anaesthetics. Our model 
demonstrates total ropivacaine serum maximum concentrations range between 0.27 
and 0.87 mg/l. Since central nervous system – and cardiovascular toxicity threshold of 
ropivacaine in venous blood serum has been described to be 2.2 mg/l,18 serum levels of 
ropivacaine in our study never exceed these toxicity levels. 
Therefore we can conclude that LIA with ropivacaine in the doses described in our 
study is safe for patients. 
As for other local anaesthetics, our profile describes flip-flop kinetics, with a rapid 
initial phase (Tmax = 6.0 h; range 2.8 - 9.3) followed by a second peak in the curve after 
admission of the first LIA injection. This flip-flop kinetics is also described for ropiva-
caine during continuous epidural infusion.14 At the time of the second peak, patients 
in our study are being mobilised by a physiotherapist. This rehabilitation therapy can 
contribute to increased perfusion of the hip joint and therefore can cause an increased 
transport of ropivacaine to the perfusing blood. This could be a possible cause for this 
second peak in ropivacaine after LIA for THA. Because of this flip-flop kinetics, absorp-
tion and disposition kinetics could not directly be derived from the concentration-time 
curve. Therefore, the computer program MwPharm was used in our study to describe 
pharmacokinetic models. According to AIC, the most appropriate model was chosen.
Some potential limitations of our study need to be addressed. First, our statement 
about toxicity of the determined ropivacaine serum levels is based on ropivacaine levels 
in venous blood serum. In bolus injections, arterial blood serum concentrations could be 
at much higher level compared to venous blood serum concentrations. Hence venous 
blood serum might not be representative for systemic toxicity effects on various parts 
of the body after this bolus injection. However, since Tmax in our study is 6 hours, venous 
blood serum concentrations are not likely to be detectable lower than those of arterial 
blood serum. Moreover, no toxic adverse effects (e.g. cardiovascular or central nervous 
system effects) were reported in our study.
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Second, only 12 patients were included in this study. We could not perform a clear 
sample size calculation, since no relevant literature on concentration-time correlation 
of ropivacaine in serum could be found. Therefore we decided to perform a pilot study 
with 12 patients. 
Third, although all patients in our study received same amounts of ropivacaine, Cmax 
ranged from 0.27 to 0.87 mg/l. The amount and function of hepatic enzymes CYP3A4 and 
CYP1A2 are different for each patient, which causes differences in metabolism rates and 
drug concentrations. Furthermore, despite standardised injection sites for LIA in THA, it 
is assumed that ropivacaine is not precisely equally injected in the surgical field for all 
patients in our study. This can lead to a different diffusion profile from the joint capsule 
into the blood, which may contribute to these inter-patient differences as well. Until 
now, specific patient characteristics were never taken into account, and further research 
including more patients is required to investigate these inter-patient differences more 
precisely. 
In conclusion, this pilot-study demonstrates a pharmacokinetic model for absorption 
and diffusion of ropivacaine after LIA for THA. Pharmacokinetic parameters after LIA in 
THA are clarified, and these parameters do not differ from those of TKA. Therefore, other 
causes than pharmacokinetic parameters of ropivacaine are responsible for lack of effect 
of LIA after THA. It seems not likely that a higher dose of ropivacaine can optimise the 
effect of LIA after THA. Serum levels of ropivacaine in our study never exceeded toxic-
ity levels. Further research is required to investigate inter-patient differences in serum 
maximum ropivacaine concentrations more precisely.
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AbsTrACT
In our hospital a fast-track setting including a multimodal pain protocol is used for total 
hip arthroplasty (THA). Despite this multimodal pain protocol there is still a large range 
in reported postoperative pain between patients, which hinders mobilization and reha-
bilitation postoperatively. The goal of this study was to identify which patient-specific 
and surgical characteristics influence postoperative pain after THA in a fast-track setting.
All 74 patients with osteoarthritis of the hip who underwent primary THA procedure 
by anterior supine intermuscular approach between November 2012 and January 2014 
were included in this prospective cohort study. The protocol for pain medication was 
standardized. 
Postoperative pain determined with the Numeric Rating Score was collected at 17 
standardized moments. Linear mixed models were used to examine potential patient-
specific and surgical factors associated with increased postoperative pain.
Pain patterns differed substantially across individuals. Adjusted for other variables in 
the model, preoperative use of pain medication (regression coefficient 0.78 (95%CI 
0.28 – 1.26); p = 0.005) and preoperative neuropathic pain scored by DN4 (regression 
coefficient 0.68 (95%CI 0.15 – 1.20); p = 0.02) were the only factors significantly associated 
with higher postoperative pain scores. 
The knowledge of which factors are associated with higher postoperative pain scores 
after THA in a fast-track setting may help optimizing perioperative postoperative pain 
management and preoperative education of these patients. 
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InTrOduCTIOn 
Total hip arthroplasty (THA) is associated with considerable postoperative pain.1 
Almost all pain after surgery arises as a result of tissue damage at the surgical site.2 
This postoperative pain hinders early mobilization and rehabilitation with subsequent 
consequences on mobility and overall recovery.3 In the last few years fast-track protocols 
have been introduced worldwide for elective primary THA. These are partly based on 
pain management protocols and include a rigorous perioperative pain management 
program, which allow for an optimized perioperative period.4,5 In 2009, a fast-track pro-
tocol including a multimodal pain protocol was successfully introduced in our teaching 
hospital.6 The multimodal pain protocol, developed to reduce acute postoperative pain 
to enable quick mobilization and rehabilitation included paracetamol, celecoxib, gaba-
pentine, dexamethasone and esketamine.7-12 Furthermore, we use the anterior supine 
intermuscular (ASI) approach for THA procedures in our hospital. Since this approach 
uses both an intermuscular and internervous plane and causes less surgical trauma, 
lower postoperative pain scores and less pain medication consumption have been 
described for this approach.13-18 Despite the introduction of a multimodal pain protocol 
and use of the ASI approach, there is still a large range in reported postoperative pain 
between patients.
Previous studies have shown that specific patient- and provider characteristics could 
influence postoperative pain.19-27 Only one of these studies reported solely on postop-
erative pain after primary THA.21 None of these studies were performed in a fast-track 
setting and no multimodal pain protocols developed to reduce acute postoperative 
pain were included in these studies.
The proper identification of patients who are at risk to experience more postoperative 
pain directly after primary THA might provide details for further optimization of post-
operative pain management and preoperative education of these patients. Therefore, 
the goal of this study was to identify which patient-specific and surgical characteristics 
influence postoperative pain after primary THA by ASI approach in a fast-track setting 
including a multimodal pain protocol.
PATIenTs And MeTHOds 
All 74 patients with osteoarthritis of the hip who underwent primary THA procedure 
by ASI approach between November 2012 and January 2014 were included in this 
prospective cohort study. All procedures were performed in a fast-track setting, by 
one experienced orthopedic hip surgeon (SV). Patients with neurological conditions 
which potentially influence pain perception; American Society of Anaesthesiologists 
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(ASA) classification III/IV; medical contra-indication for spinal anesthesia; cardiovascular 
impairment in the present or past; known allergy against any element of the medication 
that is given for the multimodal pain protocol; abuse of alcohol or drugs; rheumatoid 
arthritis; BMI > 40 kg/m2; and patients with cognitive impairment were excluded.
All patients received spinal anesthesia with a low dose of bupivacaine (6-8 mg intrathe-
cally). Propofol was administered for sedation and to allow a single shot of esketamine. 
The multimodal protocol for perioperative pain medication was standardized (Table 1). 
Before discharge, adequate pain relief had to be achieved by oral pain medication: the 
Numeric Rating Score (NRS) for pain had to be below 3 in rest and below 5 during mobi-
lization (NRS; 0 to 10, best to worst). 
Postoperative pain determined with the NRS was collected at 17 standardized moments, 
from 1 hour after surgery until the afternoon of the second day after surgery (Table 2).
Potential factors associated with increased postoperative pain (gender; ASA classifi-
cation; age; BMI; diabetes mellitus (DM); surgery time; incision length; living situation; 
preoperative pain determined with the NRS, preoperative use of pain medication; use 
of antidepressants; as well as preoperative scores of the neuropathic pain diagnostic 
questionnaire (DN4), and Amsterdam Preoperative Anxiety and Information Scale 
(APAIS) for anxiety and information requirements) were examined with univariable lin-
ear mixed models for repeated measures. Decision to include these variables was based 
Table 1: The standardized multimodal protocol for perioperative pain medication. 
Timing Medication
2 hours before 
surgery
Paracetamol (acetaminophen) 1000 mg per os.
Celecoxib (Celebrex®)* 400 mg per os.
Gabapentin 600 mg per os.
Just before surgery Dexamethasone 0.15 mg/kg iv.† 
Esketamine 15 mg iv.
4 hours after surgery Paracetamol (acetaminophen) 1000 mg per os.
8 hours after surgery Paracetamol (acetaminophen) 1000 mg per os.
Gabapentin 300 mg per os.
Before the night Tramadol 100 mg supp.
Day 1 Paracetamol (acetaminophen) 1000 mg per os 4 times a day.
Celecoxib (Celebrex®)* 200 mg per os in the morning.
Gabapentin 300 mg per os in the morning.
After day 1 Paracetamol (acetaminophen) 1000 mg per os 4 times a day (with a maximum of 2 
weeks).
Celecoxib (Celebrex®)* 200 mg per os in the morning (until 2 weeks after surgery).
Rescue medication Celecoxib (Celebrex®)* 200 mg per os extra after the first night
Dipidolor 10 mg im, which could be repeated every 4 hours.
*In combination with celecoxib (Celebrex®) all patients will receive omeprazol 20 mg per os once a day as pro-
phylaxis. When the patient was already using a proton pomp inhibitor before admittance no omeprazol was 
administered. † Dexamethasone solution in 50cc saline is administered slowly to avoid adverse side affects like 
severe perianal pain.
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on guidance from directed acyclic graphs.28 Based on the criteria in the original article 
about the APAIS by Moerman and others,29 the APAIS anxiety scale was dichotomized 
(4-10: no, 11-20: yes), and the APAIS need-for-information scale was divided into three 
categories (2-4: no or little, 5-7: average, and 8-10: high). The DN4 questionnaire score 
was dichotomized (1-3 unlikely; 4-7 likely).30,31 Factors that were associated with the out-
come in univariable analyses (p-values < 0.20) were included in multivariable analyses. 
In the multivariable analyses p-values less than 0.05 were considered significant. Missing 
data were assumed to be missing at random. Regression coefficients are presented with 
their 95% confidence intervals. The statistical analyses were performed using R version 
3.1.2 with package ‘nlme’.32,33
resulTs 
Mean age of all patients was 67.1 year (range 42.7 – 84.6) and mean BMI was 27.1 kg/m2 
(range 20.1 – 38.9). Mean LOS was 1.8 nights (range 1 - 7). Most patients lived together 
with cohabitants (n = 58; 78.4 %) and were discharged to their own home (n = 72; 97.3 %). 
Patient characteristics are listed in Table 3.
73 patients received an uncemented prostheses (Taperloc® femoral prosthesis and an 
Universal® cup, both Biomet, Warsaw, In, USA), one patient received a cemented pros-
thesis because of inferior bone quality due to severe osteoporosis. (Exceed Muller® cup 
and a Taperloc® femoral prosthesis, both Biomet, Warsaw, In, USA). 
Pain patterns differed substantially across individuals. Moreover, pain varied across 
the standardized moments (Table 4). Adjusted for the other factors in the model, pre-
operative use of pain medication (regression coefficient 0.78 (95%CI 0.28 – 1.26); p = 
0.005) and preoperative neuropathic pain scored by DN4 (regression coefficient 0.68 
Table 2: Postoperative pain determined with the NRS was collected at 17 standardised moments, from 1 
hour after surgery until the afternoon of the second day after surgery.
Baseline Baseline (n=74)
Day 0 1 hour postoperative (n=69)
4 hours postoperative (n=74)
Before (n=65) & after mobilization (n=72)
8 hours postoperative (n= 69)
Day 1 Morning (n=67)
Before (n=72) & after mobilization (n=71)
Afternoon (n=60)
Before (n=54) & after mobilization (n=54)
Day 2 Morning (n=39)
Before (n=41) & after mobilization (n=41)
Afternoon (n=14)
Before (n=15) & after mobilization (n=15)
132 Chapter 9 
9
(95%CI 0.15 – 1.20); p = 0.02) were the only factors that were significantly associated with 
higher postoperative pain scores (Table 5). All other factors demonstrated no effect on 
postoperative pain.
Table 3: Patient characteristics for the total group of 74 patients undergoing primary total hip arthroplasty. 
Total n (%)
n = 74
Age (year) 67.1 (42.7 – 84.6)*
BMI (kg/m2) 27.1 (20.1 – 38.9)*
Gender male 36 (48.6 %)
ASA classification ASA2 47 (63.5 %)
Surgery time (minutes) 79.2 (49 - 116)*
Diabetes Mellitus 7 (9.5 %)
Incision length (cm) 9.97 (7.5 – 12.0)*
Living situation with cohabitants 58 (78.4 %)
Preoperative antidepressants use 4 (5.4 %)
Preoperative pain medication use 50 (67.6 %)
Preoperative pain (NRS)† 5.26 (0 - 9)*
DN4 likely 16 (21.6 %)
APAIS anxiety yes 15 (23.1 %)
APAIS information no/little 24 (37.5 %)
average 24 (37.5 %)
high 16 (25.0 %)
* mean (range) , † n = 72 patients
Table 4: Pain scores determined with the NRS at the standardized moments.
NRS N mean (range)
Preoperative 72 5.26 (0.0 – 9.0)
Day of surgery 1 h 69 1.51 (0.0 – 8.0)
4 h 74 2.97 (0.0 – 9.0)
Before mobilization 69 2.62 (0.0 – 6.0)
After mobilization 65 2.93 (0.0 – 10.0)
8 h 72 2.40 (0.0 – 8.0)
Day 1 Morning 67 1.63 (0.0 – 5.0)
Before mobilization 72 1.71 (0.0 – 7.0)
After mobilization 71 2.25 (0.0 – 9.0)
Afternoon 60 1.57 (0.0 – 6.0)
Before mobilization 54 1.26 (0.0 – 4.0)
After mobilization 54 1.73 (0.0 – 6.0)
Day 2 Morning 39 2.00 (0.0 – 7.0)
Before mobilization 41 1.54 (0.0 – 6.0)
After mobilization 41 1.84 (0.0 – 4.5)
Afternoon 14 1.82 (0.0 – 3.0)
Before mobilization 15 1.27 (0.0 – 3.0)
After mobilization 15 1.93 (0.0 – 4.0)
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dIsCussIOn 
The aim of this study was to identify which patient-specific and surgical characteristics 
influence postoperative pain after primary THA by ASI approach in a fast-track setting, 
using a multimodal pain protocol which was developed to reduce acute postoperative 
pain to enable quick mobilization and rehabilitation. The only two factors associated 
with increased postoperative pain adjusted for the other factors in the model, were 
preoperative use of pain medication (regression coefficient 0.78 (95%CI 0.28 – 1.26); p 
= 0.005) and preoperative neuropathic pain scored by DN4 (regression coefficient 0.68 
(95%CI 0.15 – 1.20); p = 0.02).
In our study, we used a multimodal pain protocol, including paracetamol, celecoxib, 
gabapentin, dexamethasone and esketamine.7-12 This pain protocol is part of a fast-track 
setting and is developed to reduce acute postoperative pain to enable patients to quickly 
mobilize and rehabilitate in an optimized and safe perioperative period.4,5 Mean post-
operative pain score determined with the NRS collected at 17 standardized moments, 
varied from 1.51 (range 0.0 – 8.0) to 2.97 (range 0.0 – 9.0). These results demonstrate 
that the use of our multimodal pain protocol enables adequate postoperative pain relief 
in which patients are able to mobilize and rehabilitate quickly. However, despite this 
Table 5: Regression coefficients with 95% CIs for potential factors associated with increased postoperative 
pain after THA in a fast-track setting.
Univariable analyses Multivariable analysis
coefficient (95% CI) p-value coefficient (95% CI) p-value
Age 0.006 (-0.02 – 0.03) 0.66 - -
BMI 0.03 (-0.03 – 0.09) 0.28 - -
Gender male vs. female -0.31 (-0.79 – 0.18) 0.22 - -
ASA classification ASA2 vs. ASA1 0.30 (-0.21 – 0.80) 0.25 - -
Surgery time -0.01 (-0.03 – 0.0005) 0.06 0.0004 (-0.01 – 0.01) 0.96
Diabetes Mellitus -0.05 (-0.88 – 0.78) 0.92 - -
Incision length 0.02 (-0.26 – 0.31) 0.89 - -
Living situation with cohabitants vs. 
alone
0.53 (-0.05 – 1.10) 0.08 0.50 (-0.08 – 1.07) 0.11
Preoperative 
antidepressants use
yes vs. no 0.66 (-0.39 – 1.71) 0.22 - -
Preoperative pain 
medication use
yes vs. no 0.68 (0.18 – 1.18) 0.009 0.78 (0.28 – 1.26) 0.005
Preoperative pain 0.10 (-0.01 – 0.21) 0.08 -0.02 (-0.13 – 0.09) 0.73
DN4 likely vs. unlikely 0.70 (0.13 – 1.28) 0.02 0.68 (0.15 – 1.20) 0.02
APAIS anxiety yes vs. no -0.06 (-0.67 – 0.54) 0.84 - -
APAIS information average vs. no/little -0.02 (-0.61 – 0.56) 0.93 -0.21 (-0.74 – 0.31) 0.45
high vs. no/little 0.50 (-0.16 – 1.15) 0.15 0.45 (-0.12 – 1.02) 0.15
Factors that were associated with the outcome in univariable analyses (p-values < 0.20) were included in a mul-
tivariable linear mixed model for repeated measures. In the multivariable analyses p-values less than 0.05 were 
considered significant. 
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pain protocol, a large range in reported postoperative pain between patients still exists, 
including some outliers with high postoperative pain scores.
Pain has been described to be a sensory and emotional experience that is influenced 
by multiple factors.34,35 Although several other studies reported on effects of specific 
patient- and provider characteristics on postoperative pain,19-27 none of these studies 
were performed in a fast-track setting with a multimodal pain protocols developed to 
reduce acute postoperative pain (and hence enable early mobilization), were included 
in these studies. Since no literature reports on the effect of potential factors associated 
with increased postoperative pain in a fast-track setting, our model included various 
potential factors that have been described to be associated with postoperative pain 
based on a non-fast-track setting.19-27,36 The use of a multimodal pain protocol in our 
study might have influenced the effects of these characteristics on postoperative pain 
and could be a reason for discrepancy between our results and results of these other 
studies.
Preoperative use of pain medication provides information on the preoperative pain 
levels of patients and has been shown to be associated with more severe postoperative 
pain.26,27 Our study supports these findings. In contrast, another study on postoperative 
pain 12 to 24h after elective abdominal surgery, demonstrated no effect of preoperative 
use of pain medication on postoperative pain.23
Our multimodal protocol for postoperative pain medication was standardized for all 
patients. The effect of this pain protocol might therefore not be sufficient for single pa-
tients who are used to pain medication. On the other hand, in a study on postoperative 
pain after thoracic surgery a decrease in postoperative pain medication use for patients 
who used pain medication preoperatively was found.37
DN4 is a validated questionnaire for neuropathic pain,30,31 which was preoperatively 
scored for all patients in our study. The differences between neuropathic pain and 
non-neuropathic (nociceptive) pain have been described in literature.30 Osteoarthritis, 
the main indication for THA in our study, causes non-neuropathic pain.30 Patients who 
experience non-neuropathic pain from osteoarthritis preoperatively, are more likely to 
benefit from THA and will experience less pain postoperatively. Since preoperative neu-
ropathic pain is not caused by osteoarthritis of the hip,30 THA will probably not resolve 
this neuropathic pain. As a consequence, these patients will be more likely to experience 
more postoperative pain after primary THA.
In the present study, none of the other factors were significantly associated with 
postoperative pain. All of these potential factors have been described to be associated 
with postoperative pain in non-fast-track setting studies.19-27,36 Contrasting results on 
the effect of age on postoperative pain have been reported in literature, including an 
association between younger age and a higher level of postoperative pain20,23,24,27 as 
well as a lack of effect of age on the level of postoperative pain.26,38
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BMI has been shown to be associated with an increased inflammatory response,38 
which is related to higher levels of postoperative pain,39 whereas others demonstrated 
no effect of BMI on postoperative pain scores.24,39,40 In our study we excluded patients 
with BMI > 40 kg/m2, which might be a reason for lack of effect of BMI on postoperative 
pain.
Regarding gender, contrasting results on the effect on postoperative pain have been 
reported in literature as well. These results include both higher postoperative pain for 
female patients24,27,38 and no effect of gender on postoperative pain.22,23,25,26
Higher ASA classification has also been shown to be associated with increased post-
operative pain.23 However, in our study we only included patients with ASA classification 
I or II, which might be a reason for lack of effect of ASA classification on postoperative 
pain.
An increased incision length results in increased tissue damage, and might subse-
quently result in increased postoperative pain. This relation has been described in 
literature.24 In our study the ASI approach was used. Since this approach uses both an 
intermuscular and internervous plane, less surgical trauma and hence lower postopera-
tive pain scores and less pain medication consumption have been described.13-18
Use of antidepressants provides information on patients’ mental state, which could be 
predictive for the patients’ response on pain medication and pain experience.25 More-
over, in literature depression symptoms have been mentioned to be related to higher 
level of postoperative pain.23,38,41
Furthermore, we used different validated questionnaires preoperatively for all 
patients to define preoperative pain and pain characteristics, including the APAIS.29 
Anxious patients respond differently to anesthesia and pain than non-anxious patients 
and therefore require larger doses of anaesthetics.19,20,25,42,43 It has been reported that 
the anxiety/‘worry’ component of the APAIS is positively associated with the occurrence 
of early postoperative pain, whereas a strong information seeking behavior reduces the 
incidence of severe postoperative pain.24 This is in contrast to others who report that 
patients who require more information about impending discomforts preoperatively 
may sensitize the individual to the experience.19
Some potential limitations of our study should be discussed. First, only 74 patients 
were included. However, simulation studies showed that with mixed models with 
relatively small samples sizes, appropriate inferences regarding the point and interval 
estimates for fixed effects can be made.44,45 A strength of the present study is that linear 
mixed models, not only model the correlation between repeated measures of the same 
patient, they also assess fluctuations in postoperative pain over time. Second, although 
others investigated effects of occupation and/or level of education,19,23,40,41 SF-36,24 and 
heart rate and blood pressure36 on postoperative pain, we were not able to include 
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these variables in our model, because these variables were not reported in a consistent 
way in the patient files.
A qualitative systematic review of Ip and others36 identified factors associated with 
postoperative pain and analgesic consumption. Type of surgery was an important 
predictive factor for postoperative pain. This suggests that results of our study are ap-
plicable for primary THA. Furthermore, this could be another reason for the discrepancy 
between different studies describing postoperative pain after different types of surgery, 
besides differences in the pain protocol used.
In conclusion, only preoperative use of pain medication and preoperative neuropathic 
pain were associated with increased postoperative pain after primary THA in a fast-track 
setting, including a multimodal pain protocol which was developed to reduce acute 
postoperative pain to enable quick mobilization and rehabilitation. This knowledge 
provides further details for optimization of postoperative pain management and preop-
erative patient education.
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GenerAl COnClusIOn And PersPeCTIve
The aim of this thesis was to investigate how perioperative care for primary THA patients 
could be optimized. Three main aspects of the perioperative procedure were therefore 
studied: length of hospital stay (LOS), surgical procedure, and pain management. 
lenGTH Of HOsPITAl sTAY
Fast-track protocols combine efficient organization with analyses of core care principles 
which will ensure effective pain management, early mobilization and reduction of surgi-
cal stress and allow for optimized and safe perioperative care which will finally result in 
a reduction of LOS.1-4 However, although a reduced LOS is often thought to be the main 
goal of fast-track protocols, it is actually the result of fast-track and should merely be 
seen as a good indicator for the successful implementation of a fast-track protocol. 
A prolonged hospital stay in combination with a period of perioperative bed rest will 
have various undesirable effects and, consequently, a negative impact on perioperative 
care. Distorted sleep as a result of high noise levels at the hospital ward, as well as the 
use of certain drugs and the postoperative inflammatory response are related to early 
postoperative fatigue.5,6 A long period of postoperative bed rest results in loss of weight 
and muscle mass and associated weakness, and is therefore related to late postoperative 
fatigue.5,7 Furthermore, patients are exposed to multi-resistant microorganisms in the 
hospital as well as hospital-acquired infections.8,9 The successful implementation of a 
fast-track protocol results in a reduction of LOS and consequently in the reduction of the 
undesirable effects and negative impacts of prolonged hospital stay on perioperative 
care.
Chapter 2 describes the implementation of a fast-track protocol in a large Dutch 
teaching hospital, which led to a significant decrease in LOS for unselected THA patients 
without a change in complication rate, re-admission rate or reoperation rate. As LOS 
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decreased, we wondered whether we could achieve a further reduction in LOS and per-
form THA in an outpatient setting. Chapter 3 confirms that outpatient THA through the 
anterior approach can be performed successfully in a cohort of selected patients, with 
satisfying results up to 3 months postoperatively, and without troublesome side effects.
Since it proved possible to perform outpatient THA in selected patients, the challenge 
is to reduce the number of selection criteria to enable all patients to be treated in an 
ambulatory setting. Proper identification of patient characteristics influencing patient 
recovery might be used to improve perioperative care as well as discharge and reha-
bilitation planning. These improvements might enlarge selection criteria for outpatient 
THA in the future. Hence, proper patient identification seems the key to optimizing 
perioperative care for THA patients even further. 
However, since it might not be feasible to perform outpatient THA for all patients in 
the near future, probably specific patient categories need to be identified. Examples 
of these categories are the outpatient THA category, patients with a LOS of 1 night and 
patients who need more time to recover postoperatively such as fragile elderly. For this 
last patient category, cooperation with geriatric care for postoperative hospitalization is 
recommended to establish safe and optimized perioperative care.
Regarding proper identification of patients who need more rehabilitation time 
and extensive care, we identified outliers in LOS after the introduction of a fast-track 
procedure. Chapter 4 describes our study among 477 unselected patients who received 
primary THA in a fast-track setting, which demonstrated that older age, living alone and 
the straight lateral approach were associated with a prolonged LOS. Since two of these 
three patient characteristics, age and living situation, cannot be changed, the informa-
tion about these two characteristics can only be used for optimizing the organization of 
care regarding preoperative patient information and rehabilitation planning.
surGICAl PrOCedure
By contrast, the surgical approach is a factor in the surgical process that can be changed 
by the orthopedic surgeon in order to provide better patient care by reducing LOS, even 
though changing a surgical approach can cause learning curve issues. In the past few 
years, the anterior approach is gaining popularity in the Netherlands, with an increase 
from 4.2 % in 2010 to 9.9 % of all primary THAs in 2013.10 However, there is an ongoing 
debate whether this still less frequently used approach is preferable to other approaches 
to the hip joint and whether the possible benefits of this approach outweigh the pos-
sible disadvantages. 
Although some may consider the anterior approach just another hype in orthopedic 
surgery, beneficial results of the anterior approach have been described. In Chapter 4, 
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our own study on the effects of patient characteristics on LOS in our hospital demon-
strated an association of the anterior approach with a decrease in LOS in a fast-track 
setting, when compared to the straight lateral approach. In Chapter 5, our systematic 
review of all available literature regarding the anterior approach demonstrated benefits 
of the anterior approach in the early postoperative period as well. The purpose of this 
systematic review was to evaluate all available literature about the anterior approach 
compared to other approaches for primary THA. Long-term effects seem not to be influ-
enced by approach, whereas short-term effects are influenced positively by the anterior 
approach. However, in a fast-track setting these positively influenced short-term effects 
might provide additional benefits. 
A possible drawback of the anterior approach is the learning curve for surgeons using 
this approach. This learning curve is not yet clear. Although there is a learning curve 
for the anterior approach and this approach is sometimes criticized for its technical dif-
ficulty, our systematic review demonstrated that there was no higher risk for postopera-
tive complications or malposition of component placement when the anterior approach 
is used. Moreover, a learning curve is not unique for the anterior approach. It also exists 
for other approaches of the hip joint.
Specific complications following the anterior approach can be prevented if a surgeon 
is more experienced or if the pitfalls for this procedure are known. When we introduced 
the anterior approach (ASI) in our hospital, we noticed some specific complications for 
this approach, which could be potential pitfalls for other surgeons who perform this 
approach. Chapter 6 describes that LFCN lesions occurred more often than expected, 
and fractures of the greater trochanter and dislocations were seen as well. As a result of 
these observations, the technique was altered in order to avoid these complications in 
our hospital. 
Since the anterior approach has several early postoperative benefits, this approach 
might be a good option for orthopedic surgeons at the start of their career. If standard 
education is enlarged with this approach, and residents in orthopedic surgery are not 
only educated in the kind op approach used in their hospital, these residents can learn 
to use the anterior approach during their residency in a similar way as they learn to 
use other approaches to the hip. In view of the benefits for the anterior approach, 
experienced orthopedic surgeons should also consider converting to this approach, 
although the question remains if a surgeon who is familiar with an approach other than 
the anterior approach should convert this approach for the short-term benefits only, 
knowing that there is a learning curve. 
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PAIn MAnAGeMenT
Postoperative pain also contributes to postoperative patient burden and reduces pa-
tient satisfaction after primary THA. Furthermore, postoperative pain could hinder rapid 
postoperative mobilization.11 Perioperative analgesia of the surgical tissue theoretically 
provides less postoperative pain and therefore could result in an optimized postopera-
tive rehabilitation and faster recovery. However, chapter 7 demonstrates no effect of local 
infiltration analgesia (LIA) on postoperative pain in our randomized placebo-controlled 
trial. This trial investigated the effect of both standard and reversed LIA in combination 
with the ASI technique for primary THA. Our study only investigated patients operated 
through the ASI approach. Since the anterior approach is associated with lower post-
operative pain scores and less pain medication consumption than other approaches, 
the effect of LIA on postoperative pain might not have been detectable in our study 
population. 
Chapter 8 presents a pharmacokinetic model for the absorption and diffusion of 
ropivacaine after LIA for THA, which are similar to those after TKA. Since LIA has been 
reported to be effective in total knee arthroplasty (TKA),37,73,74 it seems unlikely that a 
higher dose of ropivacaine can optimize the effect of LIA after THA. Apparently it is not 
possible with the current LIA technique to achieve an effective blockage of all nerves 
innervating the hip joint. Therefore a possible explanation for the lack of effect of LIA in 
THA must be sought in the innervation of the hip joint. More research on local blocking 
of the nerves that innervate the hip joint is needed. Blocking these nerves might reduce 
postoperative pain even further. 
Although THA patients operated by means of the anterior approach experienced 
lower pain scores compared to patients operated by means of another approach, we 
observed patients with high pain scores postoperatively, up to an NRS of 10 for the an-
terior approach (chapter 7). All patients received as much pain medication as required. 
However, some patients, the so-called non-responders, seemed to experience more 
pain than others. Furthermore, pain patterns differed substantially across individuals. 
Therefore the question arises if other factors than postoperative pain management are 
also responsible for the amount of postoperative pain. In chapter 9 we tried to identify 
which specific patient characteristics influence postoperative pain after primary THA by 
ASI. Adjusted for other predictors in the model, preoperative use of pain medication and 
preoperative neuropathic pain scored by neuropathic pain diagnostic questionnaire 
(DN4) were the only factors that were significantly associated with higher postoperative 
pain scores after primary THA by ASI in a fast-track setting. This knowledge may help 
to further optimize the postoperative pain management and aftercare. Furthermore 
making expectations after primary THA regarding postoperative pain more reliable can 
optimize the preoperative education of these patients. 
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PersPeCTIve
In conclusion, it seems to be preferable to introduce fast-track protocols for THA, be-
cause these protocols have proven to be effective in improving postoperative outcome 
on multiple levels, and consequently in reducing LOS without troublesome side effects. 
Patient selection is not needed for these fast-track protocols. Also, it is possible to per-
form outpatient THA for selected patients. The challenge remains to reduce the number 
of selection criteria for outpatient THA.
While some may consider the anterior approach just another hype in orthopedic sur-
gery, our systematic review demonstrated early postoperative benefits for the anterior 
approach when compared to other approaches. Therefore, this approach might be a 
good option for orthopedic surgeons at the start of their career. However, in view of 
the benefits, experienced orthopedic surgeon should also consider converting to this 
approach, even though the learning curve should not be underestimated. A multimodal 
pain protocol may help to achieve adequate pain treatment after primary THA by means 
of the anterior approach, with satisfactory results for most patients. The addition of LIA 
to this protocol does not seem to have any effect and can therefore be omitted. 
All factors mentioned above will contribute to better perioperative care for primary 
THA patients and should therefore be considered in clinical practice. However, no doubt 
the challenge remains to optimize care around primary THA even further.
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In orthopedic surgery, primary total hip arthroplasty (THA) is a very commonly per-
formed surgery worldwide. It is a good option for patients with end-stage osteoarthritis 
of the hip if conservative treatment fails to alleviate pain and limitations. There is 
general agreement about this effectiveness of the surgical procedure. Prostheses have 
also improved in recent years. However, the challenge remains to optimize perioperative 
care for patients undergoing primary THA. 
The aim of this thesis was to investigate how perioperative care for primary THA 
patients could be optimized. Three main aspects of the perioperative procedure were 
therefore studied: length of hospital stay (LOS), surgical procedure, and pain manage-
ment. 
lenGTH Of HOsPITAl sTAY (lOs)
Historically, LOS after primary THA amounted to several weeks, including a long period 
of bed rest. A prolonged hospital stay in combination with a period of perioperative 
bed rest will have various undesirable effects and, consequently, a negative impact on 
perioperative care. 
In the past few years, there has been a continued interest in introducing fast-track pro-
tocols after THA. These fast-track protocols are based on analysis of core care principles 
and effective pain management and efficient organization, allowing for optimized and 
safe perioperative care and hence in a reduction of LOS.
Chapter 2 describes the implementation of a fast-track protocol in a large Dutch teach-
ing hospital.
In a retrospective cohort study we included all 1180 patients who underwent a 
primary THA between 1 July 2008 and 30 June 2012. These patients were divided into 
three groups: patients operated before, during and after the introduction of the rapid 
recovery protocol. There were no exclusion criteria. All complications, re-admissions and 
reoperations were registered and analyzed.
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The implementation of a fast-track protocol led to a significant decrease in LOS for 
unselected THA patients without a change in complication rate, re-admission rate or 
reoperation rate. 
As LOS decreased, we wondered whether we could achieve a further reduction in LOS 
and perform THA in an outpatient setting. In chapter 3 we report our experience with 
THA in an outpatient setting. In this prospective cohort study, we included 27 patients 
who were selected to receive primary THA by anterior approach in an outpatient setting 
between April and July 2014. Different patient-reported outcome measures (PROMs) 
were recorded preoperatively and at six weeks and three months postoperatively. Fur-
thermore, anchor questions on how patients functioned in daily living were scored at six 
weeks and three months postoperatively. Three of the 27 patients did not go home on the 
day of surgery because of nausea and/or dizziness. The remaining 24 patients all went 
home on the day of surgery. PROMs improved substantially in these patients. Moreover, 
anchor questions on how patients functioned in their daily living indicated that the pa-
tients were satisfied with the postoperative results. One re-admission occurred because 
of seroma formation. There were no other complications or reoperations. This confirms 
that outpatient THA through the anterior approach can be performed successfully in a 
cohort of selected patients, with satisfying results up to three months postoperatively, 
and without troublesome side effects.
Despite the reduction in LOS after the implementation of a fast-track protocol, there 
is still a wide range across the patients’ hospital duration. The purpose of chapter 4 was 
to identify which specific patient characteristics influence LOS after successful imple-
mentation of a ‘fast-track’ rehabilitation protocol. A total of 477 patients who underwent 
primary THA procedure between 1 February 2011 and 31 January 2013, were included in 
this retrospective cohort study. A LOS greater than the median was considered as an 
increased duration. Logistic regression analyses were performed to identify potential 
factors associated with increased durations. Median LOS was two nights, and the mean 
LOS 2.9 nights. In all, 266 patients had a length of stay of more then two nights. This 
study demonstrated that older age, living alone and the straight lateral approach were 
factors that were significantly associated with increased LOS in the multivariable logistic 
regression model. 
surGICAl PrOCedure
Although there is general agreement about the effectiveness of the surgical procedure 
itself, various surgical approaches for primary THA have been described. Each of these 
approaches has its own advantages and disadvantages. In the past few years, the ante-
rior approach is gaining popularity. However, there is an ongoing debate whether this 
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still less frequently used approach is preferable to other approaches to the hip joint and 
whether the possible benefits of this approach outweigh the possible disadvantages.
Chapter 5 describes our systematic review with the purpose to evaluate literature 
regarding the anterior approach in comparison to other approaches. Furthermore, we 
investigated if there is a description of a learning curve for the anterior approach.
Data were obtained from EMBASE, Cochrane, PsycINFO, CINAHL, Web-of-Science, Sco-
pus, Google scholar, and PubMed since their inception up to June 2015. Two reviewers 
independently selected the studies and independently conducted the quality assess-
ment. Because studies were considered heterogeneous regarding outcome measures, 
determinants studied, and methodological quality, we decided to perform a “best evi-
dence synthesis”. A total of 64 studies met the inclusion criteria.
Strong evidence for no difference in component placement between the anterior ap-
proach and other approaches was found. Also, strong evidence for faster postoperative 
recovery and less need for assistive devices after the anterior approach were found. All 
other studied parameters only demonstrated conflicting evidence. This demonstrates 
long-term effects seem not to be influenced by approach, whereas short-term effects 
are influenced positively by the anterior approach. Although the learning curve for the 
anterior approach is not yet clear, this learning curve should not to be neglected. 
When we introduced the anterior approach (anterior supine intermuscular (ASI) 
approach) in our hospital, we noticed some specific complications for this approach, 
which could be potential pitfalls for other surgeons who perform this approach. Chapter 
6 describes these specific complications. Injury to the lateral femoral cutaneous nerve 
(LFCN), fractures of the greater trochanter and dislocation were specific complications 
that were noticed with the initial technique. We applied specific adjustments on the 
procedure to prevent these complications. We retrospectively analyzed the differences 
between 202 patients who were operated by a standardized anterior approach and 248 
patients who were operated after adjustments were implemented on the procedure. 
Prevalence of injury to the LFCN decreased from 7.9 % to 0.8 % (p < 0.001), fractures of 
the greater trochanter decreased from 5.4 % to 0.8 % (p = 0.004) and the incidence of 
dislocation decreased from 4.5 % to 1.6 % (p = 0.074).
PAIn MAnAGeMenT
THA is associated with considerable postoperative pain. This postoperative pain hinders 
early mobilization and rehabilitation, which has negative consequences on mobility, 
LOS and duration of overall recovery. Analgesics are used to provide pain relief. However, 
most analgesics are known for their side effects. Therefore, the challenge of analgesic 
regimes for THA is to obtain adequate pain relief without troublesome side effects. 
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Local infiltration analgesia (LIA) is a technique in which the surgical field is infiltrated 
with analgesics (ropivacaine) in order to provide better pain relief postoperatively. Only 
limited data are available regarding the infiltration of local anaesthetic for THA and no 
studies were performed for THA using the anterior approach. 
Chapter 7 describes a prospective, randomized placebo-controlled study in which we 
investigated the effect of both standard and reverse infiltration of local anaesthetic in 
combination with the anterior approach for THA. The primary endpoint was the mean 
numeric rating score (NRS) for pain four hours postoperatively. In addition, we recorded 
the length of hospital stay, the operating time, the destination of the patient at dis-
charge, the use of pain medication, the occurrence of side effects and pain scores at 
various times postoperatively.
Between November 2012 and January 2014, 75 patients were included in the study. 
They were randomized into three groups: standard infiltration of local anaesthetic, 
reversed infiltration of local anaesthetic, and placebo. We found no clinically relevant 
effect when the infiltration of local anaesthetic with ropivacaine and epinephrine was 
used in a multimodal pain protocol for THA using the anterior approach. 
The reason for lack of effect of LIA for THA is not yet clear. The purpose of chapter 
8 was to elucidate pharmacokinetic parameters of ropivacaine administered by LIA in 
THA patients. For determining ropivacaine serum concentrations, blood samples were 
collected at multiple moments from just before infiltration, until 48 hours after infiltra-
tion of the first LIA mixture. This pilot-study demonstrates a pharmacokinetic model 
for absorption and diffusion of ropivacaine after LIA for THA. These parameters do not 
differ from those for total knee arthroplasty. It seems not likely that a higher dose of 
ropivacaine can optimise the effect of LIA after THA. Serum levels of ropivacaine in our 
study never exceeded toxicity levels.
The fast-track protocol for THA in our hospital includes a multimodal pain protocol. 
Despite this pain protocol there is still a large range in reported postoperative pain be-
tween patients, which hinders mobilization and rehabilitation postoperatively. The goal 
of chapter 9 was to identify which patient-specific and surgical characteristics influence 
postoperative pain after THA in a fast-track setting. All 74 patients with osteoarthritis of 
the hip who underwent primary THA procedure by ASI approach between November 
2012 and January 2014 were included in this prospective cohort study. The protocol for 
pain medication was standardized. Postoperative pain determined with the NRS was 
collected at 17 standardized moments. Linear mixed models were used to examine 
potential patient-specific and surgical factors associated with increased postoperative 
pain. Pain patterns differed substantially across individuals. Adjusted for other variables 
in the model, preoperative use of pain medication and preoperative neuropathic pain 
scored by DN4 were the only factors significantly associated with higher postoperative 
pain scores. The knowledge of which factors are associated with higher postoperative 
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pain scores after THA in a fast-track setting may help optimizing perioperative postop-
erative pain management and preoperative education of these patients.
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Wereldwijd is de primaire totale heup prothese (THP) een frequent uitgevoerde ortho-
pedische operatie. Het is een goede optie voor behandeling van pijn en beperkingen bij 
patiënten met vergevorderde artrose van de heup, indien conservatieve behandeling 
faalt. Er bestaat algemene consensus over de effectiviteit van deze operatieve ingreep. 
Ook zijn de heupprotheses zelf de laatste jaren verbeterd. Er blijft echter een uitdaging 
bestaan om de perioperatieve zorg voor patiënten die een THP operatie ondergaan 
verder te optimaliseren. 
Het doel van dit proefschrift is te onderzoeken hoe deze perioperatieve zorg voor 
primaire THP patiënten geoptimaliseerd kan worden. Drie hoofdaspecten van de peri-
operatieve procedure werden daarvoor bestudeerd: opnameduur in het ziekenhuis, de 
chirurgische procedure zelf en pijn behandeling. 
OPnAMeduur In HeT zIekenHuIs
Historisch bedroeg de opnameduur na het plaatsen van een THP enkele weken, dit was 
inclusief een lange periode van bedrust. Verlengde opnameduur in combinatie met een 
periode van bedrust heeft verscheidene ongewenste effecten met als consequentie een 
negatieve invloed op perioperatieve kwaliteit van zorg. In de afgelopen jaren is er een 
toenemende interesse ontstaan voor de introductie van fast-track protocollen, ook na 
THP. Deze fast-track protocollen zijn gebaseerd op de analyse van basis zorg principes, 
effectieve pijn behandeling en efficiënte organisatie. Dit zorgt voor een geoptimali-
seerde en veilige perioperatieve zorg met als gevolg een afname van opnameduur.
Hoofdstuk 2 beschrijft de introductie van een fast-track protocol in een groot Neder-
lands opleidingsziekenhuis. In een retrospectieve cohort studie includeerden we alle 
1180 patiënten die primaire THP ondergingen tussen 1 juli 2008 en 30 juni 2012. Deze 
patiënten werden verdeeld in drie groepen: patiënten geopereerd voor, tijdens en na de 
introductie van het fast-track protocol. Er waren geen exclusie criteria. Alle complicaties, 
heropnames en heroperaties werden geregistreerd en geanalyseerd. De invoer van een 
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fast-track protocol leidde tot een significante afname van opnameduur voor een groep 
ongeselecteerde THP patiënten, zonder een verandering in aantallen complicaties, 
heropnames of heroperaties.
Aangezien de opnameduur significant afnam na de introductie van een fast-track 
protocol, ontstond de vraag of nog een verdere afname van opnameduur te bereiken 
zou zijn en of het mogelijk zou zijn om THP in dagbehandeling uit te voeren. In hoofd-
stuk 3 rapporteren we onze ervaring met THP in dagbehandeling. In deze prospectieve 
cohort studie includeerden we 27 patiënten die waren geselecteerd voor primaire THP 
via voorste benadering in dagbehandeling, tussen april en juli 2014. Verschillende 
patient-reported outcome measures (PROMs) werden zowel preoperatief als zes weken 
en drie maanden postoperatief bijgehouden. Tevens werden anchor questions over hoe 
patiënten functioneerden in het dagelijks leven gescoord, zes weken en drie maanden 
postoperatief. Drie van de 27 patiënten gingen niet met ontslag op de dag van de ope-
ratie als gevolg van misselijkheid en/of duizeligheid. De overige 24 patiënten gingen 
allen naar huis op de dag van de operatie. PROMs verbeterden substantieel voor deze 
patiënten. Verder gaven de anchor questions aan dat patiënten tevreden waren met de 
postoperatieve resultaten. Eén heropname vond plaats als gevolg van seroomvorming. 
Er waren geen overige complicaties of heroperaties. Dit bevestigt dat THP middels de 
voorste benadering in dagbehandeling succesvol kan worden uitgevoerd, met goede 
resultaten tot aan drie maanden postoperatief en zonder dat ernstige complicaties 
optreden. 
Ondanks de afname van opnameduur na de introductie van een fast-track protocol, 
bestaat er nog steeds een forse spreiding in opnameduur tussen de verschillende 
patiënten. Het doel van hoofdstuk 4 is om te identificeren welke specifieke patiënten 
karakteristieken deze opnameduur beïnvloedden, na de succesvolle invoer van een 
fast-track protocol. Een totaal van 477 patiënten ondergingen een primaire THP tussen 
1 februari 2011 en 31 januari 2013. Zij werden geïncludeerd in deze retrospectieve cohort 
studie. Een opnameduur van meer dan de mediaan werd beschouwd als een verlengde 
opnameduur. Multivariabele logistische regressie analyses werden uitgevoerd om 
potentiele factoren te identificeren welke geassocieerd zijn met een verlengde opname-
duur. De mediaan van opnameduur was twee nachten en de gemiddelde opnameduur 
was 2.9 nachten. Van alle patiënten hadden 266 een opnameduur van meer dan twee 
nachten. Deze studie toonde aan dat oudere leeftijd, alleen wonen en de straight lateral 
benadering factoren waren welke geassocieerd zijn met een toegenomen opnameduur.
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CHIrurGIsCHe PrOCedure
Ondanks dat er algemene consensus bestaat over het effect van de chirurgische pro-
cedure zelf, worden er verschillende chirurgische benaderingen voor primaire THP be-
schreven. Elk van deze benaderingen heeft zijn eigen voor- en nadelen. In de afgelopen 
jaren is de voorste benadering fors in populariteit toegenomen. Er bestaat echter een 
voortdurende discussie of deze minder frequent gebruikte benadering naar het heup-
gewricht te prefereren is boven andere benaderingen en of de mogelijke voordelen van 
deze benadering opwegen tegen eventuele nadelen er van.
Hoofdstuk 5 beschrijft ons sytematic review waarin de literatuur geëvalueerd wordt 
aangaande de voorste benadering. Deze benadering wordt vergeleken met de andere 
benaderingen. Verder onderzochten we of er een duidelijke definitie bestaat voor de 
learning curve voor de voorste benadering.
Data werden verkregen uit EMBASE, Cochrane, PsycINFO, CINAHL, Web-of-Science, 
Scopus, Google scholar, en PubMed sinds het ontstaan tot en met juni 2015. Twee re-
viewers selecteerden onafhankelijk van elkaar de studies en voerden onafhankelijk van 
elkaar quality assessments uit. Omdat de studies heterogeen werden beschouwd met 
betrekking tot de uitkomstmaten, bestudeerde determinanten en methodologische 
kwaliteit, werd er besloten om een “best evidence synthesis” uit te voeren. Een totaal 
van 64 studies voldeed aan de inclusie criteria.
Er werd sterk bewijs gevonden dat er geen verschil bestaat in postoperatieve com-
ponent positie tussen de voorste benadering en andere benaderingen. Verder werd 
er sterk bewijs gevonden voor sneller postoperatief herstel en minder gebruik van 
hulpmiddelen indien de voorste benadering wordt gebruikt voor THP. Alle overige 
bestudeerde parameters lieten slechts tegenstrijdig bewijs zien. Dit laat zien dat lange 
termijn effecten niet beïnvloed lijken door de gekozen benadering, terwijl korte termijn 
effecten positief beïnvloed worden door het gebruik van de voorste benadering. On-
danks dat de learning curve voor de voorste benadering niet geheel duidelijk is, moet 
deze learning curve niet genegeerd worden.
Tijdens de introductie van de voorste benadering (anterior supine intermuscular (ASI) 
approach) in ons ziekenhuis, bemerkten we een aantal specifieke complicaties voor 
deze benadering, welke potentiële valkuilen kunnen zijn voor andere chirurgen die 
deze benadering gaan gebruiken. Hoofdstuk 6 beschrijft deze specifieke opgemerkte 
complicaties. Letsel aan de n.cutaneus femoralis lateralis, fracturen van het trochanter 
major en luxaties van de heup waren specifieke complicaties welke opvielen bij de 
initiële techniek. Er werden specifieke aanpassingen gedaan aan de chirurgische proce-
dure om deze complicaties te voorkomen. Wij analyseerden retrospectief de verschillen 
tussen 202 patiënten welke waren geopereerd via de standaard voorste benadering en 
248 patiënten welke waren geopereerd nadat de aanpassingen aan de procedure waren 
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gedaan. Het voorkomen van letsel aan de  n.cutaneus femoralis lateralis nam af van 7.9 
% naar 0.8 % (p < 0.001), fracturen van het trochanter major namen af van 5.4 % naar 0.8 
% (p = 0.004) en luxaties van de heup namen af van 4.5 % naar 1.6 % (p = 0.074).
PIjn beHAndelInG
De THP operatie is geassocieerd met aanzienlijke postoperatieve pijn. Deze pijn hindert 
vroege mobilisatie en revalidatie, wat negatieve consequenties heeft op mobiliteit, 
opnameduur en duur van het totale herstel. Analgetica worden gebruikt als pijnstilling. 
Echter de meeste analgetica staan bekend om hun bijwerkingen. Er bestaat daardoor 
een uitdaging om adequate pijnstilling rondom de THP operatie te bereiken zonder dat 
daarbij vervelende bijwerkingen optreden. 
Local infiltration analgesia (LIA) is een techniek waarbij het operatiegebied geïnfil-
treerd wordt met een lokaal analgeticum (ropivacaine), met als doel om postoperatief 
betere pijnstilling te verkrijgen. Er zijn slechts beperkte data beschikbaar met betrekking 
tot het gebruik van LIA bij THA en in geen van deze studies werd de voorste benadering 
voor THP uitgevoerd. Hoofdstuk 7 beschrijft een prospectieve gerandomiseerde place-
bo-gecontroleerde studie waarin we het effect van zowel standaard als omgekeerde LIA 
onderzoeken in combinatie met de voorste benadering voor THP. Primair eindpunt van 
deze studie was de gemiddelde numeric rating score (NRS) vier uur postoperatief. Daar-
naast werden opnameduur, operatieduur, ontslagbestemming van de patient, gebruik 
van pijnmedicatie, het voorkomen van bijwerkingen, en pijnscores op verschillende 
postoperatieve tijdstippen bijgehouden. Tussen november 2012 en januari 2014 werden 
75 patiënten geïncludeerd in deze studie. Ze werden gerandomiseerd in drie groepen: 
standaard LIA, omgekeerde LIA en standaard placebo. We vonden geen klinisch relevant 
verschil tussen deze drie groepen met betrekking tot de verschillende uitkomstmaten.
De reden voor gebrek aan effect van LIA voor THP is niet geheel duidelijk. Het doel 
van hoofdstuk 8 was derhalve om de farmacokinetische parameters van ropivacaine te 
onderzoeken wanneer dit wordt toegediend middels LIA in THP patiënten. Om de ropi-
vacainie serum concentraties te bepalen werden bloedmonsters verzameld op verschil-
lende momenten, van net voor de infiltratie tot en met 48 uur na de infiltratie van het 
eerste LIA mengsel. Deze pilotstudie toont een farmacokinetisch model voor absorptie 
en diffusie van ropivacaine van LIA na THP. Deze parameters verschillen niet van die van 
LIA na totale knieprothese. Het lijkt dan ook niet waarschijnlijk dat een hogere dosis 
ropivacaine het effect van LIA na THP kan optimaliseren. Serum levels van ropivacaine in 
onze studie overschreden nooit de toxiciteits-grens. 
Het fast-track protocol voor THP in ons ziekenhuis bevat een multimodaal pijn 
protocol. Ondanks het gebruik van dit pijn protocol bestaat er een grote spreiding in 
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gerapporteerde postoperatieve pijn scores tussen patiënten. Het doel van hoofdstuk 
9 was om te identificeren welke patient specifieke en chirurgische karakteristieken 
invloed hebben op postoperatieve na THP in een fast-track setting. Alle 74 patiënten die 
een primaire THP middels voorste benadering ondergingen voor artrose van de heup, 
tussen november 2012 en januari 2014 werden geïncludeerd in deze prospectieve cohort 
studie. Het protocol voor pijn medicatie was gestandaardiseerd. Postoperatieve pijn 
bepaald middels NRS werd bijgehouden op 17 gestandaardiseerde momenten. Lineair 
mixed models werden gebruikt om potentiele patient specifieke en chirurgische facto-
ren te onderzoeken welke geassocieerd waren met toegenomen postoperatieve pijn. 
Pijn patronen verschilden substantieel tussen de verschillende individuen. Gecorrigeerd 
voor de overige variabelen in het model waren preoperatief gebruik van pijn medicatie 
en preoperatieve neuropatische pijn, gescoord met de DN4, de enige factoren welke 
significant geassocieerd waren met hogere postoperatieve pijn scores. Deze kennis 
kan helpen om perioperatieve pijn behandeling en preoperatieve educatie van deze 
patiënten te optimaliseren. 
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